Podcasts about American Academy

n this episode, Shawn Martin, Executive Vice President and Chief Executive Officer, American Academy of Family Physicians, discusses the growing momentum behind independent primary care, the financial and policy challenges facing physicians, and how AI could help reshape the future of family medicine. He also shares why affordability and innovation will define healthcare's next chapter.

Podcast summary of articles from the June 2026 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include mechanical ventilation, C-spine trauma, pre-hopsital ketamine, difficulty airway, post intubation sedation, and ostomy complications.  Guest speaker is Dr. Kinda Sweidan.

Un nouvel épisode du Pharmascope est disponible! Dans ce 181e épisode, Nicolas, Olivier, Amélie et une invitée d'expérience poursuivent leur discussion sur la dermatite atopique en pédiatrie. Cette deuxième partie est consacrée aux autres traitements topiques que les corticostéroïdes et aux traitements systémiques.  Les objectifs pour cet épisode sont les suivants: Discuter de l'évaluation et du diagnostic de la dermatite atopique en pédiatrie. Discuter des de la prise en charge et des différents traitements de la dermatite atopique en pédiatrie. Discuter de l'efficacité et l'innocuité des corticostéroïdes pour le traitement de la dermatite atopique en pédiatrie. Ressources pertinentes en lien avec l'épisode  AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel; Chu DK, et coll. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol. 2024 Mar;132(3):274-312. Davis DM, et coll. Guidelines of care for the management of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2026 Apr. 3e1-26. Chu DK, et coll. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023 Dec;152(6):1493-1519. Luger T, Chu CY, Elgendy A, Ibrahim SBBK, Murashkin N, Ranjan S, Zhao Z. Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas. Eur J Dermatol. 2023 Oct 1;33(5):474-486. Cury Martins J, et coll Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. Paller AS, et coll. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016 Sep;75(3):494-503.e6. Simpson EL, et coll. Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials. JAMA Dermatol. 2024 Nov 1;160(11):1161-1170. doi: 10.1001/jamadermatol.2024.3121. Eichenfield LF, et coll. Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study. J Am Acad Dermatol. 2025 Sep;93(3):689-698. Silverberg JI, et coll. Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials. J Am Acad Dermatol. 2024 Sep;91(3):457-465. Paller AS, et coll. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2020 Nov;83(5):1282-1293. Paller AS, et coll. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial. JAMA Dermatol. 2023 Jun 1;159(6):596-605.

Can stem cell therapy help the body repair itself? Learn how stem cells may influence inflammation, immune function, tissue regeneration, brain health, and aging.Stem cell therapy is one of the most talked-about areas of regenerative medicine, but not all stem cells or treatments are the same. In this episode, Dr. Joy Kong explains how stem cells work, why their source matters, and what patients should investigate before choosing a treatment or clinic.We explore the differences between bone marrow, fat-derived, and umbilical cord-derived stem cells, along with IV infusions, local injections, PRP, and exosomes. Dr. Kong also discusses emerging research and clinical observations involving chronic inflammation, neurological health, joint pain, skin, hair loss, aging, and cancer.Many of the treatments and potential applications discussed remain experimental and are not established treatments for the conditions mentioned. This conversation is for educational purposes and should not replace individualized medical advice.Subscribe for weekly health and longevity breakdowns, and comment below: Would you ever consider stem cell therapy?If you are managing chronic inflammation, exploring ways to support healthy aging, or looking for personalized cancer support, explore related Hol+ care options here:Inflammation:https://holplus.co/conditions/inflammation/Longevity and Anti-Aging:https://holplus.co/services/longevity-anti-aging/0:00 Can Stem Cells Help the Body Heal?0:57 Meet Dr. Joy Kong7:28 What Is a Stem Cell?14:49 Bone Marrow, Fat, and Umbilical Cord Stem Cells17:10 How to Evaluate Stem Cell Quality and Safety23:00 IV Stem Cells, Injections, PRP, and Exosomes33:45 Stem Cells and Cancer40:26 Brain Health and Neurological Conditions42:20 Skin, Hair, Anti-Aging, and Weight Loss48:01 The Future of Stem Cell Medicine55:19 Stem Cell Costs and Overseas Clinics59:04 Dr. Kong's Approach to Health and LongevityAbout Dr. Joy Kong:Dr. Joy Kong is a UCLA-trained, triple board-certified physician specializing in anti-aging and regenerative medicine. She is the founder of the American Academy of Integrative Cell Therapy, where she educates physicians about stem cell therapy and other regenerative treatments.After beginning her career in psychiatry, Dr. Kong became interested in stem cells after learning about their potential applications beyond conventional symptom management. Her work now focuses on regenerative medicine, stem cell therapy, peptides, longevity, and educating patients and physicians about this rapidly developing field.Connect with Dr. Joy Kong:https://joykongmd.com/https://www.instagram.com/dr_joy_kong/https://www.youtube.com/@joykongmdhttps://chara-health.com/podcast/About Dr. Taz:Dr. Tasneem Bhatia (Dr. Taz) is a triple board-certified integrative medicine physician,bestselling author, and founder of hol+ a multi-location integrative medicine practice.Learn more: https://doctortaz.com/aboutStay Connected:Connect further to Hol+ at https://holplus.co/ - Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.Book a Hol+ Consultation: https://holplus.co/locations/virtual/Follow Dr. Taz on Instagram:https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Subscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsProduced by https://ClipGrowth.com (Producer: Pat Gostek)

"We have an untapped army of 200,000 PAs that really could step up and drive some change in the healthcare system if we weren't restricted,” says Dr. Jennifer Kolb, capturing her motivation for pushing to update practice regulations for physician associates that date back more than 50 years.  As Chief Medical Officer and Senior Vice President of Clinical Affairs at the American Academy of Physician Associates, Dr. Kolb has been in the middle of the fight at the state and federal level to grant PAs more independence from physicians, full billing rights, and the increased ability to practice across state lines, among other changes.  In this pertinent conversation with Raise the Line host Lindsey Smith, Dr. Kolb explains how these updates could help close huge gaps in access to healthcare, better manage the fight against chronic diseases and improve patient outcomes.   Dr. Kolb also addresses:  Why the name shift from "assistant" to "associate" took her years to fully appreciate; How a 10-year gap in life expectancy across Chicago zip codes shapes her view of health equity; Why PA's shouldn't wait for permission to start making change in their communities. Mentioned in this episode:American Academy of Physician Associates   If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

HEALTH NEWS   Review finds blueberry and grape polyphenols may improve vascular health Plant compound shows promise for treating rheumatoid arthritis at its source, study finds Screen Time at Ages 1 and 6 Linked to Lasting Learning and Memory Effects Some caffeinated drinks are linked to poorer memory Study: Morning Exercise Linked to Lower Daily Calorie Intake Compared to Evening Workouts   Review finds blueberry and grape polyphenols may improve vascular health Universidad Católica de Murcia (Spain), July 27 2026 (News-Medical) A recent review published in the journal Nutrients examined the evidence on the effects of blueberries, grapes, and their bioactive compounds on cardiovascular risk markers. In the present study, a comprehensive systematic literature search was conducted to identify randomized controlled trials (RCTs), systematic reviews, and meta-analyses published from January 2015 through April 2026.  Two systematic reviews and meta-analyses reported that grape polyphenols at doses exceeding 500 mg/day for at least 12 weeks significantly reduced C-reactive protein levels, while the other reported improvements in vascular function or BP in 84% of the human studies it assessed, including a significant reduction in systolic BP. One found a modest reduction in BP and improvement in endothelial function with flavan-3-ol foods, such as tea, apples, cocoa, and grape-derived products. Moderate- and high-quality RCTs reported improvements in lipid peroxidation, lipid profiles, flow-mediated dilation, diastolic BP, and paraoxonase activity. Resveratrol and blueberry RCTs mainly reported endothelial and vascular benefits, such as improved nitric oxide production and flow-mediated dilation and reduced BP and inflammatory markers. One high-quality RCT involving older men with metabolic syndrome showed significant improvements in arterial stiffness and endothelial function after six months of daily blueberry consumption.     Plant compound shows promise for treating rheumatoid arthritis at its source, study finds Guangzhou University of Chinese Medicine, July 27 2026 (Natural News) A plant-derived compound called obakulactone (OL) reduced swelling, inflammation and joint damage in rats with rheumatoid arthritis, according to a study published in Engineering.   The compound, a tetracyclic triterpenoid from the bark of Phellodendri cortex, also rebalanced immune activity and corrected disrupted fatty acid metabolismd. P. cortex has been used in traditional medicine and contains OL along with other constituents, Researchers tested OL in rats with rheumatoid arthritis, administering low, medium and high doses for 21 days. Treatment significantly reduced joint swelling and helped restore the normal structure of cartilage and the synovium, the tissue lining the joints, according to the report.   Blood tests showed dose-dependent decreases in inflammatory molecules including IL-1, IL-6, IL-17 and TNF, as well as rheumatoid arthritis markers RF, CCP-Ab, CRP and MMP-3, officials said. The compound also reduced abnormally high levels of CD3+ T cells and CD68+ macrophages within the joints and shifted macrophages from a proinflammatory M1 state toward an anti-inflammatory M2 state.   Screen Time at Ages 1 and 6 Linked to Lasting Learning and Memory Effects National University of Singapore & Zhejiang University (China), July 28, 2026 (SciTech Daily) A study that tracked children from age 1 through age 8 found that greater screen viewing time, especially during infancy and near the start of school, was associated with lower academic performance at age 9 and weaker working memory at age 10.5. The results indicate that when children use screens may matter as much as how long they spend using them. The World Health Organization (WHO) and the American Academy of Pediatrics advise avoiding screens before 18 to 24 months and limiting viewing to less than one hour per day between ages 2 and 5. Many children exceed those recommendations, yet previous research on screens and cognitive development has produced inconsistent results. The analysis included 502 children followed from infancy into middle childhood. Higher screen viewing during particular stages was associated with poorer academic results and weaker working memory later on. The clearest and most consistent relationships appeared during infancy and near school entry, suggesting that these may be especially sensitive periods for cognitive development. Children with greater total screen exposure across childhood also generally performed less well in school. Together, the findings suggest that both the timing and overall amount of viewing may have implications for learning and memory.   Some caffeinated drinks are linked to poorer memory Applied Science Private University (Jordan), July 28 2026 (News-Medical) A recent study in the Journal of Education and Health Promotion examined the association between caffeine-containing products and memory performance, anxiety, and stress among university students in Jordan. 204 students were ultimately included in the study.  Mild psychological distress was the most common category, with 38.2% reporting such symptoms. About four in ten reported mild depression, and over a quarter experienced moderate anxiety. Only a small minority showed severe or extremely severe stress. Caramel or nut-filled chocolate was the most frequently consumed item, reported by 54.9% of students, followed by Arabic coffee (40.2%) and red tea (35.8%). Milk chocolate was also popular, typically consumed once or twice a day. Dark chocolate was less common, while American coffee and green tea were less popular, and decaffeinated coffee was rarely chosen. Overall DASS scores, representing depression, anxiety, and stress symptoms, showed positive correlations with the consumption of dark chocolate, American/instant coffee, decaffeinated coffee, and red tea, indicating these items were linked to higher psychological distress scores. Memory ability was negatively associated with higher intake of American coffee, Arabic coffee, and soft drinks.  The authors note that chocolate and green tea also contain bioactive compounds such as cocoa flavanols and L-theanine, which may have contributed to these associations alongside caffeine.   Study: Morning Exercise Linked to Lower Daily Calorie Intake Compared to Evening Workouts Copenhagen University Hospital (Denmark), July 27 2026 (Natural News)   A new study has found that morning exercise was associated with lower calorie consumption throughout the day compared to evening workouts, according to the research. Participants who exercised in the morning consumed about 400 fewer calories at the post-workout meal and roughly 547 fewer calories over the full 24-hour period, the study reported.   The study, which involved 35 healthy young adults. Each participant completed 30 minutes of treadmill running multiple times under varying conditions: morning fasted, evening fasted for 12 hours or 6 hours, and morning or evening fed, the study stated. The repeated-measures design enabled researchers to compare the same person's responses across different scenarios, officials said. After evening sessions, participants reported higher hunger, a stronger desire to eat, and lower fullness compared to morning sessions, the study found. Those who worked out in the evening consumed about 400 more calories at the post-workout meal and roughly 547 more calories over the full day, according to the research.   The appetite advantage was attributed to circadian rhythms, researchers said. The hunger hormone ghrelin naturally rises in the evening, while satiety hormones are more active in the morning,.

Richard Blanco joins Kevin Young to read and discuss “Questions of Travel,” by Elizabeth Bishop, and his own poem, “My Father in English.” Blanco is the author of two memoirs and four poetry collections, including “How to Love a Country” and “Homeland of My Body.” He is the recipient of several honors, including a National Humanities Medal, a Lambda Literary Award, a Paterson Poetry Prize, and a Thom Gunn Award for Gay Poetry. He was selected by President Barack Obama as the fifth inaugural poet in United States history, and was named as the first-ever American Academy of Poets education ambassador.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Meena Hasan (born 1987, NYC) received her B.A. from Oberlin College in 2009 and her MFA from Yale School of Art in 2013, where she won the Carol Schlosberg Memorial Prize for Painting. In 2010, she was awarded the Terna Prize Affiliated Fellowship at the American Academy in Rome and in 2025 she was an artist-in-residence in the Winter TNT Residency hosted by Transmitter and Tiger Strike Asteroid Galleries in NYC. She has participated in group exhibitions at the Kristen Lorello Gallery, NYC, Klaus von Nichtssagend Gallery, NYC, Center for Book Arts, NYC, The Stedelijk Museum, Den Bosch, The Netherlands, Deitch Projects, NYC, Nathalie Karg Gallery, New York, NY, the 2022 New England Triennial at the deCordova Sculpture Park and Museum and Fruitlands Museum and at BRIC Arts and Media in Downtown Brooklyn in Spring of 2023 among others. Recent two-person and solo exhibitions have been shown at The Old Stone House of Brooklyn, NY, Main Window, Dumbo with Deanna Evans Projects, NYC, and Stowaway Gallery, Los Angeles, CA all in 2025. Meena has taught Painting at Rutgers University – Newark, Pratt Institute’s Painting MFA program, the School of Visual Arts at Boston University and Studio in a School, NYC. She is currently the Graduate Program Director and Associate Professor in Painting at RISD, Providence and lives and works in Brooklyn, NY. Meena Hasan, jaali 1 (after matisse’s seated odalisque with haiti textile, 1926) acrylic, Flashe, Okawara paper, Tyvek, image transfer, copper pipe, climbing rope, carabiners, 85 x 40 inches Meena Hasan, jaali 1 (detail, after matisse’s seated odalisque with haiti textile, 1926) acrylic, Flashe, Okawara paper, Tyvek, image transfer, copper pipe, climbing rope, carabiners, 85 x 40 inches Meena Hasan, Terrible Beauty, at Main Window Dumbo, Was On View: June 5 – August 20, 2025, 1 Main Street, Brooklyn, NY Meena Hasan, Terrible Beauty (Detail), at Main Window Dumbo, Was On View: June 5 – August 20, 2025, 1 Main Street, Brooklyn, NY

Claire Vaye Watkins is the author of the novel Yellow Pine, available from Riverhead Books. Her other books include the story collection Battleborn and the novels Gold Fame Citrus and I Love You But I've Chosen Darkness. She has received the Story Prize, the Dylan Thomas Prize, the New York Public Library's Young Lions Fiction Award, and the Rosenthal Family Foundation Award from the American Academy of Arts and Letters. A National Book Foundation 5 Under 35 honoree, Watkins is a professor at the University of California, Irvine. *** Today's episode is brought to you by Rula. Thousands of people are already using Rula to get affordable, high-quality therapy that's actually covered by insurance. Visit ⁠⁠⁠⁠⁠⁠⁠⁠www.rula.com/otherppl⁠⁠⁠⁠⁠⁠⁠⁠ to get started. *** ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Otherppl with Brad Listi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ is a weekly podcast featuring in-depth interviews with today's leading writers. Available where podcasts are available: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, etc. Get ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠How to Write a Novel,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ the debut audio course from DeepDive. 50+ hours of never-before-heard insight, inspiration, and instruction from dozens of today's most celebrated contemporary authors. Subscribe to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Brad's email newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Support the show on Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Merch⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bluesky⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email the show: letters [at] otherppl [dot] com The podcast is a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠proud affiliate partner of Bookshop⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, working to support local, independent bookstores. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this Q&A episode of our Postural Orthostatic Tachycardia Syndrome (POTS) series, host Paul Wirkus, MD, FAAP and guest Kirti Sivakoti, MD, answer listener questions about diagnosing and managing POTS in pediatric patients. The discussion explores how to distinguish POTS from conditions with overlapping symptoms, including Mast Cell Activation Syndrome (MCAS) and other common POTS mimics, and when referral to an immunologist may be appropriate.We also review commonly used medications for symptom management, including practical considerations for initiating and tapering therapy as patients improve. Additional topics include the effects of caffeine, stimulant medications, ADHD treatments, and vasoconstrictors on orthostatic symptoms, helping clinicians navigate treatment decisions in children and adolescents with complex presentations.Throughout the episode, Dr. Sivakoti emphasizes the importance of individualized care, careful assessment, and ongoing follow-up to optimize outcomes for patients living with POTS.Have a question? Email questions@vcurb.com. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

What does it take to carve out a career that's both technically demanding and personally fulfilling? In this episode of Everyday Oral Surgery, Dr. Grant Stucki sits down with Dr. Jon Perenack to discuss the path that led him from oral and maxillofacial surgery training in Canada and Louisiana to building one of the country's leading facial cosmetic surgery practices. Dr. Perenack talks about the mentors who shaped his career, how unexpected events created new opportunities, and why he ultimately chose to leave academia for private practice. He shares his philosophy on surgical excellence, the importance of continuous learning, and what it takes to build a successful cosmetic practice. Finally, Dr. Perenack explains how creativity, teaching, and family have helped build his life both inside and outside the operating room. Tune in now!Key Points From This Episode:Find out how Dr. Perenack's training and fellowship led him into facial cosmetic surgery.Hear how Hurricane Katrina unexpectedly changed the course of his career.Dr. Perenack offers advice for OMS residents interested in cosmetic surgery.Explore why facial cosmetic surgery creates a unique patient experience.Discover which habits Dr. Perenack thinks every OMS surgeon should practice.How loupes, ergonomics, and the right equipment can benefit your surgical career.Learn where early-career cosmetic surgeons can gain career experience.He shares how painting and creativity influence life outside the operating room.The one surgical instrument Dr. Perenack says transformed his practice.His advice on family, perspective, and making the most of time with your children.Links Mentioned in Today's Episode:Dr. Jon Perenack – https://www.drperenack.com/Dr. Jon Perenack on Instagram – https://www.instagram.com/drjonperenackDr. Jon Perenack on Facebook – https://www.facebook.com/drjonperenackBefore and After Gallery: Dr. Jon Perenack – https://www.drperenack.com/before-after-galleriesWilliamson Cosmetic Center & Perenack Aesthetic Surgery – https://www.williamsoncosmeticcenter.com/The LigaSure™ – https://www.medtronic.com/en-us/healthcare-professionals/products/surgical-energy/vessel-sealing/ligasure-technology.htmlBALANCE ADVANCE Microsurgery Chair – https://www.brumaba.com/operating-chairs/operation-and-microsurgery-chair-balance-advance/American Association of Oral and Maxillofacial Surgeons (AAOMS) – https://aaoms.org/The American Academy of Cosmetic Surgery (AACS) – https://cosmeticsurgery.org/Your Friends & Neighbors – https://www.imdb.com/title/tt30459041/Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

Claire Vaye Watkins was born in Bishop, California and raised in the Mojave Desert on the Amargosa River. A graduate of the University of Nevada Reno, she earned her MFA from the Ohio State University in 2010. Claire is the author of three novels—Gold Fame Citrus, I Love You but I've Chosen Darkness, and Yellow Pine—and the short story collection Battleborn. She has received the Story Prize, the Dylan Thomas Prize, the New York Public Library's Young Lions Fiction Award, the Rosenthal Family Foundation Award from the American Academy of Arts and Letters, the Silver Pen Award from the Nevada Writers Hall of Fame, as well as fellowships from the Lannan Foundation and the Guggenheim Foundation. Her fiction and essays have appeared in Alta, One Story, The Believer, The Paris Review, Tin House, McSweeny's, BOMB, The New Republic, Either/Or, Freeman's, New York Magazine, The Nevada Independent, The New York Times and elsewhere. She was included in Granta's “Best Young American Novelists” and the National Book Foundation's “5 Under 35.” Claire is on the board of the Amargosa Conservancy and a professor in the Programs in Writing at the University of California, Irvine. She lives in Orange County and the Mojave Desert.

This lecture was recorded by Melissa Lane on the 11th of June 2026Melissa Lane is the Class of 1943 Professor of Politics, Princeton University and is also Associated Faculty in the Department of Classics and Department of Philosophy. Previously she was Senior University Lecturer at Cambridge University in the Faculty of History and Fellow of King's College, Cambridge.She studied for her first degree in Social Studies (awarded summa cum laude) at Harvard University, and then took an MPhil and PhD in Philosophy at the University of Cambridge, where she was a student at King's College, supported by appointments as a Marshall Scholar, Truman Scholar, and Mary Isabel Sibley Fellow of Phi Beta Kappa.Professor Lane is an author, lecturer and broadcaster who has received major awards including being named a Guggenheim Fellow, and the Lucy Shoe Meritt Resident in Classical Studies at the American Academy in Rome. She has published widely in journals and authored or introduced nine major books including Greek and Roman Political Ideas; Eco-Republic; and most recently, Of Rule and Office: Plato's Ideas of the Political, which was awarded the 2024 Book Prize of the Journal of the History of Philosophy, and was published in a paperback edition with modifications in 2025.Professor Lane is the only person ever to have delivered both the Carlyle Lectures and the Isaiah Berlin Lectures at the University of Oxford.The transcript of the lecture is available from the Gresham College website: https://www.gresham.ac.uk/watch-now/ciceroGresham College has offered free public lectures for over 400 years, thanks to the generosity of our supporters. There are currently over 2,500 lectures free to access. We believe that everyone should have the opportunity to learn from some of the greatest minds. To support Gresham College's mission, please consider making a donation: https://www.gresham.ac.uk/get-involved/support-us/make-donation/donate-today Website:  https://gresham.ac.ukX: https://x.com/GreshamCollegeFacebook: https://facebook.com/greshamcollegeInstagram: https://instagram.com/greshamcollegeBluesky: https://bsky.app/profile/greshamcollege.bsky.social TikTok: https://www.tiktok.com/@greshamcollegeSupport Us: https://www.gresham.ac.uk/get-involved/support-us/make-donation/donate-todaySupport the show

In this episode of our Postural Orthostatic Tachycardia Syndrome (POTS) series, we look beyond diagnosis and treatment to discuss what the future holds for children and adolescents living with POTS. Host Paul Wirkus, MD, FAAP and guest Kirti Sivakoti, MD, review the long-term prognosis, highlighting what is currently known about recovery, symptom progression, and functional outcomes over time.The conversation also explores the complex relationship between POTS and other conditions, including the impact of COVID-19, eating disorders, chronic pain syndromes, and functional neurologic disorders. We discuss how these overlapping conditions can influence diagnosis, management, and quality of life, and examine where current research is headed as our understanding of POTS continues to evolve.Finally, our Dr. Sivakoti shares what they believe is the most misunderstood aspect of POTS and identifies one of the most undervalued interventions that can make a meaningful difference for patients. This episode offers practical insights into the evolving science of POTS while reinforcing the importance of a comprehensive, individualized approach to care.Have a question? Email questions@vcurb.com. Listener questions will be answered next week.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Send us Fan MailThe early years of birth to five are a time of rapid growth in a child's body, brain, and social-emotional development, and they can shape lifelong health and learning. Today, we'll explore what parents, caregivers, and early childhood professionals should know about preventive care, nutrition, sleep, safety, developmental milestones, and when to seek support if something doesn't seem quite right. This is our regular feature Small Wonders, partnering with the Georgia Chapter of the American Academy of Pediatrics. Our special guest is Dr. Nicola Chin, President of Georgia Chapter of the American Academy of Pediatrics.  Dr. Chin is a pediatrician in Atlanta and is affiliated with Children's Healthcare of Atlanta. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice for more than 20 years. Support the show

One of the characteristics of life is that living organisms gather information and put it to use. Even one of the simplest lifeforms, bacteria, are able to sense features of their surroundings and alter their behavior accordingly. Most impressively, they are able to sense the presence of similar bacteria by a process called quorum sensing. Today's guest, Bonnie Bassler, is a leader in this field, and explains how quorum sensing allows groups of bacteria to do things (including in our bodies) that wouldn't be possible for individual bacteria. Blog post with transcript: https://preposterousuniverse.com/podcast/2026/07/20/361-bonnie-bassler-on-how-bacteria-talk-and-work-together/ Support Mindscape on Patreon. Bonnie Bassler received a Ph.D. in biochemistry from Johns Hopkins University. She is currently Andrew K. Golden University Professor of Molecular Biology at Princeton University and a Howard Hughes Medical Institute Investigator. She is a member of the National Academy of Sciences, National Academy of Medicine, and the American Academy of Arts and Sciences. Among her awards are a MacArthur Fellowship, the Gruber Prize in Genetics, and the National Medal of Science. Lab web site Princeton web page Google Scholar publications Wikipedia

Link for CME credit coming soon! This episode examines a recent tragic case involving a teenage cheerleader and how it raises questions about energy drinks and cardiovascular health in young people. Host Holly Wayment and pediatric cardiologist Dr. Elaine Maldonado reviews what is known and unknown about high-caffeine beverages, common symptoms they can cause (palpitations, chest pain, racing heart), and the American Academy of Pediatrics' guidance that children generally should avoid caffeine. The conversation also highlights that some local high schools sell energy drinks in vending machines and even offer coffee bars on campus, making these products widely accessible to adolescents. Practical takeaways include lifestyle alternatives, red flags warranting urgent care (persistent fast heart rate, chest pain, passing out with exertion), and advice for pediatricians and families on counseling teens about caffeine use.

What if our obsession with “dangerous” sun is killing us?If you (recklessly) leave your urban office for lunch, you are told to yank your hat down low. If you (again, recklessly) let your kids dash into the backyard, you are told to slather them in sunscreen—or learn to live with the guilt.And yes, sun avoidance undoubtedly prevents some skin cancers, including the deadliest type, melanomaBut a recent study suggests sunlight contributes to hundreds of thousands of deaths every year in the United States alone—orders of magnitude more than the estimated 8400 annual US melanoma deaths.In this episode, we discuss evidence linking sun avoidance toalmost a million annual deaths in the US and Europe alone, exceeding the number caused by global military conflictsbreast, pancreatic, colon, and lung cancers, as well as heart disease, high blood pressure, and stroketo INCREASED risk of death in those diagnosed with sun-induced melanoma.Yes, you read that right; some melanoma deaths may be related to too little sunlight.  (But do understand that this is complex--sunlight DOES cause melanoma. Well, some melanomas....)We also discuss why supplementing with vitamin D pills fails to remedy these terrible conditions, and what a thoughtful person can do instead, while staying safe.We hope you enjoy this episode, and that it helps you enjoy the sun again--thoughtfully, of course. References and further reading:  Sunlight: Time for a Rethink?Benefits of oral Polypodium leucotomas extract in MM high risk patients (This is an ingredient in Life Extension's Shade Factor, mentioned in this episode by Dr. Gordon). Uses of Polypodium leucotomos Extract in Oncodermatology  Calzari et alInsufficient Sun Exposure Has Become a Real Public Health Problem. Alfredsson L, Armstrong BK, Butterfield DA, et al. International Journal of Environmental Research and Public Health. 2020;17(14):E5014. doi:10.3390/ijerph17145014.Prospective Study of Ultraviolet Radiation Exposure and Risk of Cancer in the United States. Lin SW, Wheeler DC, Park Y, et al. International Journal of Cancer. 2012;131(6):E1015-23. doi:10.1002/ijc.27619.An Estimate of Premature Cancer Mortality in the U.S. Due to Inadequate Doses of Solar Ultraviolet-B Radiation. Grant WB. Cancer. 2002;94(6):1867-75. doi:10.1002/cncr.10427.Solar Ultraviolet-B Exposure and Cancer Incidence and Mortality in the United States, 1993-2002. Boscoe FP, Schymura MJ. BMC Cancer. 2006;6:264. doi:10.1186/1471-2407-6-264.Ecological Studies of the UVB-vitamin D-Cancer Hypothesis. Grant WB. Anticancer Research. 2012;32(1):223-36.Sunlight Exposure in Association With Risk of Lymphoid Malignancy: A Meta-Analysis of Observational Studies. Kim HB, Kim JH. Cancer Causes & Control : CCC. 2021;32(5):441-457. doi:10.1007/s10552-021-01404-6.Adulthood Residential Ultraviolet Radiation, Sun Sensitivity, Dietary Vitamin D, and Risk of Lymphoid Malignancies in the California Teachers Study. Chang ET, Canchola AJ, Cockburn M, et al. Blood. 2011;118(6):1591-9. doi:10.1182/blood-2011-02-336065.Is Prevention of Cancer by Sun Exposure More Than Just the Effect of Vitamin D? A Systematic Review of Epidemiological Studies. van der Rhee H, Coebergh JW, de Vries E. European Journal of Cancer (Oxford, England : 1990). 2013;49(6):1422-36. doi:10.1016/j.ejca.2012.11.001.An Ecologic Study of Cancer Mortality Rates in Spain With Respect to Indices of Solar UVB Irradiance and Smoking. Grant WB. International Journal of Cancer. 2007;120(5):1123-8. doi:10.1002/ijc.22386.Does Sunlight Prevent Cancer? A Systematic Review. van der Rhee HJ, de Vries E, Coebergh JW. European Journal of Cancer (Oxford, England : 1990). 2006;42(14):2222-32. doi:10.1016/j.ejca.2006.02.024.Heliovaccination: Solar mediated immunity against cancer. Uzoigwe CE. Experimental Dermatology. 2020;29(5):477-480. doi:10.1111/exd.14087.Beneficial Health Effects of Ultraviolet Radiation: Expert Review and Conference Report. Riedmann U, Dibben C, de Gruijl FR, et al. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology. 2025;24(6):867-893. doi:10.1007/s43630-025-00743-6.A Blueprint for the Primary Prevention of Cancer: Targeting Established, Modifiable Risk Factors. Gapstur SM, Drope JM, Jacobs EJ, et al. CA: A Cancer Journal for Clinicians. 2018;68(6):446-470. doi:10.3322/caac.21496.Proportion and Number of Cancer Cases and Deaths Attributable to Potentially Modifiable Risk Factors in the United States, 2019. Islami F, Marlow EC, Thomson B, et al. CA: A Cancer Journal for Clinicians. 2024 Sep-Oct;74(5):405-432. doi:10.3322/caac.21858.Cutaneous Melanoma. Joshi UM, Kashani-Sabet M, Kirkwood JM. JAMA. 2025;334(23):2113-2125. doi:10.1001/jama.2025.13074.Sunlight, Vitamin D and the Prevention of Cancer: A Systematic Review of Epidemiological Studies. van der Rhee H, Coebergh JW, de Vries E. European Journal of Cancer Prevention : The Official Journal of the European Cancer Prevention Organisation (ECP). 2009;18(6):458-75. doi:10.1097/CEJ.0b013e32832f9bb1.Lessons Learned From Paleolithic Models and Evolution for Human Health: A Snap Shot on Beneficial Effects and Risks of Solar Radiation. Reichrath J. Advances in Experimental Medicine and Biology. 2020;1268:3-15. doi:10.1007/978-3-030-46227-7_1.PS-Vitamin D. American Academy of Dermatology (2022).American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity. Kushi LH, Byers T, Doyle C, et al. CA: A Cancer Journal for Clinicians. 2006;56(5):254-81; quiz 313-4. doi:10.3322/canjclin.56.5.254.Vitamin D, Sunlight and Cancer Connection. Holick MF. Anti-Cancer Agents in Medicinal Chemistry. 2013;13(1):70-82.Survivorship. National Comprehensive Cancer Network. Updated 2026-04-08.Keratinocyte Carcinoma. Wehner MR. JAMA. 2025;:2840731. doi:10.1001/jama.2025.18749.Public Awareness and Behaviour in Great Britain in the Context of Sunlight Exposure and Vitamin D: Results From the First Large-Scale and Representative Survey. Burchell K, Rhodes LE, Webb AR. International Journal of Environmental Research and Public Health. 2020;17(18):E6924. doi:10.3390/ijerph17186924.Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. JAMA. 2018;319(11):1134-1142. doi:10.1001/jama.2018.1623.Lifetime Sunburn Trajectories and Associated Risks of Cutaneous Melanoma and Squamous Cell Carcinoma Among a Cohort of Norwegian Women. Lergenmuller S, Rueegg CS, Perrier F, et al. JAMA Dermatology. 2022;158(12):1367-1377. doi:10.1001/jamadermatol.2022.4053.Cancer Prevention and Early Detection Facts & Figures. Rick Alteri, Deana Baptiste, Emily Butler Bell, et al. American Cancer Society (2025). Skin Cancer, Irradiation, and Sunspots: The Solar Cycle Effect. Valachovic E, Zurbenko I. BioMed Research International. 2014;2014:538574. doi:10.1155/2014/538574.Intense Solar Activity Reduces UrinarDawn Lemanne, MD Oregon Integrative OncologyLeave no stone unturned.Deborah Gordon, MDNorthwest Wellness and Memory CenterBuilding Healthy Brains

Peter Acheson was born in Washington, DC, in 1954 and received his BFA from Yale University in 1976. An early member of Williamsburg’s art scene in the 1980s, he relocated to upstate New York in the 1990s, where he continues to live and work in Columbia County. His paintings range from textured abstractions to restrained gestures that draw on a wide range of influences, including nineteenth-century French painting, Blinky Palermo, Raoul De Keyser, Bill Jensen, and Forrest Bess, alongside close observation of the landscape surrounding his studio. Acheson’s concern is less with resolving these references than it is to allow them to coexist, permitting his paintings to act as habitats where various traditions and approaches can meet without hierarchy. This carries through to Acheson’s playful way of treating his compositions, leaving them caught between styles, simultaneously structured and chaotic, with direct references and happenstance similarity. His work has been exhibited at Anton Kern Gallery, New York; Steven Harvey Fine Arts, New York; Gordon Robichaux, New York; Brennan & Griffin, New York; Novella Gallery, New York; John Davis Gallery, Hudson, New York; the American Academy of Arts and Letters, New York; Elizabeth Harris Gallery, New York; and Baumgartner Gallery, New York. His work has been discussed in Hyperallergic and The Brooklyn Rail. Peter Acheson Four Levels, 1983 – 1984 Oil on wood 8 7/8 x 11 1/8 inches (22.5 x 28.1 cm) Photography Izzy Leung, Courtesy Anton Kern Gallery Peter Acheson Untitled, 2020 Oil and stick on wood block 2 x 6 1/4 x 1 3/4 inches (5.1 x 15.9 x 4.4 cm) Photography Izzy Leung, Courtesy Anton Kern Gallery Peter Acheson Untitled, 2010-2012 Oil on wood 10 1/4 x 6 3/8 inches (26 x 16.2 cm). Photography Izzy Leung, Courtesy Anton Kern Gallery Peter Acheson Untitled, 2019 Oil on canvas 16 x 20 inches (40.6 x 50.8 cm) Photography Izzy Leung, Courtesy Anton Kern Gallery

I almost finished my July 4th call week. Good news! Portland did not blow its face off this year. No open globes, no eyelid lacerations, no thermal injuries, no sclopetaria. Bad news: a Friday holiday means every unanswered call from every patient at every one of our offices lands on the on-call doctor, and I earned every one of them. I walk through three cases. First, a cataract surgery my partner had to abort mid-procedure because the patient had six clock hours of zonule laxity. I explain what zonules actually do, why pseudoexfoliation ruins your day, and how a viscoelastic-driven pressure spike at 1 AM sent me to clinic to "burp the wound" instead of shipping the patient to the ED. Second, an inpatient consult for suspected optic disc swelling, and why nobody outside ophthalmology reliably examines an optic nerve. Third, the classic infectious disease vs. ophthalmology debate: does every asymptomatic patient with candidemia need a dilated eye exam? IDSA 2016 says yes. The American Academy of Ophthalmology says no. I'll tell you where I actually land and why I still show up anyway. Also: my full case for licensing fireworks rather than banning them, and a little pushback on the once-a-year concern for veterans and dogs. Live shows coming up in Boston and at the Lebanon Opera House in September. Takeaways: Zonule laxity, loose or broken suspensory fibers that hold the natural lens in place, can force a cataract surgeon to abort mid-procedure and refer to a retina specialist for a safer staged approach; pseudoexfoliation is one of the most common causes The viscoelastic gels used during cataract surgery can plug the eye's drainage system and cause an IOP spike that lasts up to 72 hours; oral Diamox is standard, but if the patient can't keep it down, options are IV Diamox in the ED or manually burping the wound in clinic Ophthalmologists are effectively the only clinicians reliably trained and equipped to examine the optic nerve, which is why hospitalist consults for suspected disc swelling should be treated as a normal part of the job, not an imposition The IDSA (2016) recommends dilated exams for all non-neutropenic candidemia patients within one week of diagnosis; the American Academy of Ophthalmology recommends against routine screening in asymptomatic patients. Practical approach for 2026: consult ophthalmology for any candidemia patient with visual symptoms (floaters, blurriness, pain, flashes) or who can't reliably report symptoms (intubated, delirious); asymptomatic reliable patients likely don't need routine screening To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Michael J. Breus, PhD has the distinction of being a Diplomate of the American Board of Sleep Medicine and a Fellow of The American Academy of Sleep Medicine. He is one of only 168 people in the world to have passed the Sleep Medical Speciality board without going to Medical School. World-renowned as The Sleep Doctor™, he is a bestselling author, media personality, keynote speaker, and brand advisor, bringing science-backed sleep expertise to the public for nearly three decades. Tens of millions of Americans silently struggle with poor sleep, from undiagnosed sleep apnea to chronic insomnia. SleepDoctor.com was founded to make sleep health accessible—combining clinical expertise, consumer-friendly tools, and affordable at-home diagnostics so people can finally get the rest they need. SHOWNOTES:

In this episode of VarnVlog, we are joined by Brandon Lightly to discuss the complex and often misunderstood history of Maoism. We dive deep into the theoretical underpinnings of the "mass line" and "new democracy," exploring how these concepts served as an internal critique of Marxism and a departure from Soviet-style bureaucracy.Key Topics Covered:Defining the Mass Line: Is it just populism, or a sophisticated leadership feedback loop?The Historical Origins: From the Hunan Report to the Long March and the second United Front.Theoretical Innovations: Mao's 1961 critique of Joseph Stalin and the rejection of the "Great Man" theory of history.Fragmentation: Why there are so many different Maoist tendencies (MLM, MIM, Third Worldism).Praxis: The rectification movement and the relationship between urban intellectuals and the rural peasantry.Journal ArticlesDirlik, A. (1970). The ideological foundations of the Chinese Revolution. Journal of Contemporary History, 5(3), 39–54.Dittmer, L. (1977). Line struggle: Notes on its organizational context and theoretical development. Modern China, 3(3), 303–312.Fogel, J. A. (1980). Ai Siqi, establishment intellectual by Joshua A. Fogel. Modern China, 6(1), 23–47.Hammond, E. R. (1978). Marxism and the mass line [Doctoral dissertation, University of California, Berkeley]. ProQuest Dissertations and Theses Global.Korolev, A. (2017). De-ideologized mass line, regime responsiveness, and state-society relations. China Review, 17(2), 7–36.Lyman, S. V. (1970). The Chinese Communist Party in the United Front, 1937–1945 [Doctoral dissertation, University of California, Berkeley]. ProQuest Dissertations and Theses Global.Mazur, M. G. (1995). The United Front of the 1940s: A social and cultural perspective. Modern China, 21(4), 431–456.Selden, M. (1971). The Yenan Way in revolutionary China. The China Quarterly, (45), 263–294.Steiner, H. A. (1951). Current mass line tactics in Communist China. The Annals of the American Academy of Political and Social Science, 277(1), 422–436.Teiwes, F. C. (1978). The origins of rectification: Inner-party purgation in the 1930s. The China Quarterly, (74), 181–201.Tokuda, N. (1971). The mass line during the Yenan period. The China Quarterly, (47), 1–18.Townsend, J. R. (1967). Political participation in Communist China. University of California Press.Womack, B. (1980). The phase of de-Maoization in China. China Report, 16(1), 7–21.Womack, B. (1991). Mao Zedong and the sinification of Marxism. The China Quarterly, (126), 1–15.Young, G. (1980). On New Democracy and the transition to socialism. Modern China, 6(1), 3–22.Books & Primary SourcesCoble, P. M. (2023). The collapse of Nationalist China: How Chiang Kai-shek lost China's civil war. Cambridge University Press.Elbaum, M. (2018). Revolution in the air: Sixties radicals turn to Lenin, Mao and Che. Verso Books.Hirata, K. (2024). Making Mao's steelworks: Industrial Manchuria and the transnational origins of Chinese socialism. Cambridge University Press.Karl, R. E. (2010). Mao Zedong and China in the twentieth-century world: A concise history. Duke University Press.Li, H. (2024). Fighting on the cultural front: U.S.-China relations in the Cold War. Columbia University Press.Lin, C. (2019). Mass line. In C. Sorace, I. Franceschini, & N. Loubere (Eds.), Afterlives of Chinese Communism: Political concepts from Mao to Xi (p. 122). ANU Press.Lovell, J. (2019). Maoism: A global history. Knopf Doubleday Publishing Group.Lowe, D. M. (1966). The function of "China" in Marx, Lenin, and Mao. University of California Press.Mao, Z. (1940). On New Democracy. Marxists Internet Archive.Mao, Z. (1977). A critique of Soviet economics. Monthly Review Press.Moufawad-Paul, J. (2016). Continuity and rupture: Philosophy in the Maoist terrain. Zero Books.Schram, S. R. (Ed.). (2005). Mao's road to power: Revolutionary writings 1912–1949: Vol. VII. New Democracy, 1939–1941. M.E. Sharpe.Zheng, Q. (Ed.). (2020). An ideological history of the Communist Party of China (Vol. 2) (L. Sun & S. Bryant, Trans.). Royal Collins Publishing Group.Send us Fan Mail Musis by Bitterlake, Used with Permission, all rights to BitterlakeSupport the showCrew:Host: C. Derick VarnIntro and Outro Music by Bitter Lake.Intro Video Design: Jason MylesArt Design: Corn and C. Derick VarnLinks and Social Media:twitter: @varnvlogblue sky: @varnvlog.bsky.socialYou can find the additional streams on YoutubeCurrent Patreon at the Sponsor Tier: Jordan Sheldon, Mark J. Matthews, Lindsay Kimbrough, RedWolf, DRV, Kenneth McKee, JY Chan, Matthew Monahan, Parzival, Adriel Mixon, Buddy Roark, Daniel Petrovic,Julian, Drea, Free Beer 

Samantha Rux from OSF HealthCare joined Wake Up Tri-Counties to talk about the dangers of e-bikes and electric scooters and provide safety tips for use. OSF St. Luke Medical Center is urging families to treat e-bikes and electric scooters as motor vehicles, not toys. Samantha Rux says emergency and trauma teams are seeing more child injuries linked to speed, lack of control, and limited understanding of traffic rules. Medical experts recommend helmets every ride, and some devices may call for face shields. The American Academy of Pediatrics advises riders be 16 or older for many of these devices. Doctors at OSF HealthCare Children's Hospital of Illinois in Peoria are warning families about a surge in severe e-bike and e-scooter injuries among children, especially ages 10 to 15. Pediatric trauma leaders say high-speed models can behave more like motorcycles than bicycles, raising the risk of broken bones, brain injuries, and spinal trauma. They point to the added battery weight as another danger, with crashes causing serious leg fractures and trapping riders. Physicians urge helmets, visibility, no headphones, and age-appropriate use. They're also warning families to charge batteries safely, using manufacturer-approved cords and stopping immediately if overheating, smoke, or odd smells occur. With school approaching, OSF HealthCare also reminds parents to review walking and biking safety and schedule school or sports physicals early through OSF MyChart or by calling 309-852-7700.

Welcome back to ARTMATTERS: The Podcast for ArtistsErin M. Riley is a Brooklyn-based artist whose large-scale woven tapestries explore intimacy, memory, trauma, and identity through meticulously constructed images assembled from personal photographs, found imagery, and internet culture. She received her BFA from MassArt and her MFA from Tyler School of Art, is represented by P·P·O·W in New York, and has exhibited at institutions including the Brooklyn Museum, Museion in Italy, and the 16th Lyon Biennale. Her work is held in numerous public collections, and she is the recipient of both a United States Artists Fellowship and an American Academy of Arts & Letters Art Purchase Prize.I sat down with Erin M. Riley in her Brooklyn live-work studio to talk about why she intentionally lives where she works and how weaving dictates every aspect of her daily life, physical health, exercise, fasting, posture, breathing, and endurance. We explore the importance of slowness, what it feels like to spend four months making a work you can't truly see until the very end, and the dramatic reveal after removing a finished tapestry from the loom.We talk about designing and improving weaving tools, the importance of keeping a personal archive, her fascinating system of hand-dyeing, mixing, and preparing yarn before she weaves a single stitch, and the changing place of textiles in contemporary art, and whether the old art-versus-craft debate is finally vanishing.Support this podcast by clicking HERE and becoming a Patreon Supporter!If you're enjoying the podcast so far, please rate, review, subscribe and SHARE ON INSTAGRAM!  If you have any questions you want answered, write in to artmatterspodcast@gmail.com host: Isaac Mannwww.isaacmann.cominsta: @isaac.mannguest: Erin M. Rileywww.erinmriley.cominsta: @erinmrileyThank you as always to ARRN, the Detroit-based artist and instrumentalist, for the music.

Episode Summary:In this episode of the Pain Matters podcast, Host Sudheer Potru, DO, FASA, FASAM, and Co-Host Zafeer Baber, MD, offer a comprehensive discussion of the (relatively) new analgesic medication suzetrigine, emphasizing its impact on acute pain management. Approved by the FDA in January 2025, this oral medication offers promising alternatives for moderate-to-severe postoperative pain management. Delving into its mechanism, the conversation also covers the history of voltage-gated sodium (“NAV”) 1.8 channel research and its implications for patient care.Throughout the episode, the hosts highlight suzetrigine's unique mechanism of action, acting preferentially on the NAV 1.8 sodium channels located predominantly in the peripheral nervous system. The dialogue explores its advantages over traditional opioids, including reduced side effects such as sedation and constipation, making it an attractive option for enhancing postoperative recovery protocols like ERAS (Enhanced Recovery After Surgery). The conversation expands on the complexities of treating chronic pain and the potential for new Nav channel-targeting agents to revolutionize pain management employing targeted strategies.Key Takeaways:Understanding Suzetragine: Suzetragine acts as a novel analgesic focusing on the NAV 1.8 sodium channels, offering reduced side effects compared to opioids, especially in postoperative settings.Mechanism and Discovery: The NAV 1.8 sodium channel, essential for pain signal propagation, was key to designing suzetrogine. Its function was inadvertently highlighted by genetic mutations found in individuals who couldn't feel pain due to alterations in similar channels.Economic and Clinical Implications: Although suzetrogine is more expensive than traditional pain medications, its potential to reduce hospital-acquired complications could justify its cost in clinical settings.Future Prospects in Chronic Pain: Ongoing research into suzetrogine's effectiveness for conditions like diabetic neuropathy could offer new opportunities in managing chronic pain.Broader Pharmacological Impacts: The development of NAV channel-targeted medications marks a significant milestone, signaling a shift towards more specialized pain management options.*Views expressed by our hosts and guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

Intracerebral hemorrhage carries high morbidity and mortality, but growing evidence highlights meaningful opportunities for prevention, risk reduction, and long-term recovery. This episode covers key strategies, including blood pressure management, interpretation of neuroimaging markers, and individualized decisions around antithrombotic therapy. It also emphasizes the prolonged recovery timeline and the importance of a holistic, patient-centered approach to improving outcomes. In this episode, Casey S. Albin, MD, FAAN, speaks with Wendy C. Ziai, MD, and Vishank A. Shah, MD, coauthors of the article "Intracerebral Hemorrhage" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Ziai is a professor of neurology and critical care medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Shah is an assistant professor of neurology and critical care medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland. Additional Resources Read the article: Intracerebral Hemorrhage Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Guest: @VishankShah3 Full episode transcript available here Dr Albin: A patient has suffered an intracerebral hemorrhage. They're taken to the neuro ICU, and they fortunately survive. But the journey does not end there. In fact, in some ways, the journey has just begun. Join us today as we unpack holistic care for ICH patients.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Albin: Hello to our audience. This is Dr. Casey Albin. Today, I'm interviewing Dr. Wendy Ziai and Dr. Vishank Shah about their article on intracerebral hemorrhage. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast. I am so delighted that both of you are joining. To begin, let's just do a brief introduction of who you are and, and a little bit of how you got interested in the topic.  Dr Ziai: Hi, I'm Wendy Ziai. Thank you for having me on this podcast. I am a professor of neurology at Johns Hopkins. I am a neurointensivist, and I think I got primarily interested in this topic through clinical trials that I have been a part of since my fellowship days.  Dr Shah: Hi, everyone. I'm, uh, Vishank Shah. I am also, uh, very thankful for being invited to be a part of this podcast. I'm also a neurointensivist at Hopkins and the fellowship program director here for neurocritical care, and I'm interested in recovery after ICH, and that's why I'm a part of this work.  Dr Albin: Welcome to you both. It is such a treat for me to get to interview fellow neurointensivist, particularly those who have such a wealth of experience. So, I am delighted to dive into this. All right. So, to set the stage for our audience, intracerebral hemorrhage has long been approached with pessimism. But your article really highlights that there are meaningful advantages in prevention and risk stratification and long-term recovery for these patients. Though you both are neurointensivist, this article really emphasizes primary prevention and the holistic long-term care for the survivors. And so, to begin, Dr. Shah, can you just lay out a little bit for our listeners the scope of intracerebral hemorrhage and its community impact?  Dr Shah: Yeah. So, you know, ICH is the second most common type of stroke. There are more than three million new cases of ICH globally each year, and it accounts for thirty percent of all stroke types, but it is the one that has the highest mortality, with more than forty to fifty percent of the patients dying in the first thirty days, and then continued long-term impact on both functional as well as outcomes, as well as survivorship after the early period. And it also disproportionately impacts lower socioeconomic, and then minority races like Blacks, Asians, as well as Hispanic ethnicity. And so, there's a lot of work that needs to be done to reduce the burden of this disease.  Dr Albin: Absolutely. I mean, these can really be devastating for families, and I really am appreciative of your highlighting that there's a lot of disparities, and there's a lot of work to be done to really increase equity to these patients. I think a lot of this goes into really the AAN's focus on brain health and trying to improve some of what we're doing to maintain brain health. And I really wanted to kind of drill down on this because for ICH, there's a lot that can be done upfront as we think about how do we counsel patients who may walk into the office about strategies to prevent ever becoming an intracerebral hemorrhage patient. So, Dr. Shah, can you walk us through a little bit about what neurologists in the community need to be doing to make sure that no one ends up with us in the neurointensive care unit?  Dr Shah: Yeah, sure. So, I think, you know, one of the most important risk factors is, of course, hypertension and long-standing uncontrolled hypertension. And so really recognizing the need for early onset screening with regular blood pressure monitoring at a very early age, particularly in the races that I discussed earlier. And then I think another big part, obesity, metabolic syndrome, and type two diabetes. And I think there's a lot of interesting new work that with the GLP-1 agonist, you know, in a large multicenter cohort studies showing that patients receiving these had a significantly lower reduction risk of ICH. And so, this might be a really important part that, you know, clinicians need to start increasingly recognizing and using in their practice. And then, of course, other risk factors that are common include smoking, diet high in sodium, exposure to air pollution, both indoor as well as outdoor. And so, mitigating all of these risk factors can also reduce the burden of ICH.  Dr Albin: Absolutely. And I really want to highlight that hypertension plays such an important role and that we as neurointensivist, as community neurologists, really need to be creative about ways that we can help people meet those blood pressure target and meeting people in the community where they are, making sure that they're not suffering from side effects from their medication that would prevent them from sticking with it long term. Dr. Ziai, anything else to add about what we can do in the community?  Dr Ziai: So, we really want to emphasize, even in the acute phase, that patients moving forward need to have targeted interventions to reduce blood pressure, smoking, enhance their physical activity, have a diet that is high in fruits and vegetables and low in alcohol and salt, and then promoting weight loss, of course.  Dr Albin: And Dr. Ziai, I'm gonna ask you a little bit about one of the things that maybe not all of our listeners have heard about is this APOE2, APOE4 genetic risk for intracerebral hemorrhage. What's going on there and, and should clinicians be testing for that? Dr Ziai: That's a great question, and it is not one that we currently test people for at least acute ICH presentation. APOE2 and A4- E4 alleles, these give patients a two to three times higher risk of ICH by increasing cerebral amyloid deposition. And if you happen to have APOE2 carrier ship status, then along with other risk factors like white matter disease and vascular risk factors, these predict the onset of new microbleeds even during very short follow-up periods of about two years. And as we know, having cerebral microbleeds are associated with an increased risk of all strokes, ischemic and ICH, but they are one of many MRI markers of small vessel disease, which along with cortical superficial siderosis, does significantly increase future ICH risk. And so even in people who've never had an ICH, if they happen to have an MRI, it may be reasonable to look at the MRI and incorporate this burden of small vessel disease, and especially these hemorrhagic markers into, uh, decision-making about interventions.  Dr Albin: That's a really excellent point. And so, I think that your article did a really beautiful job of thinking holistically about the patient, incorporating clinical markers of their risk for having ICH, but also those radiographic markers. I'm just gonna ask you to summarize those again one more time because not everyone will be familiar with these. So, when you're looking at an MRI, what are the things that you're particularly clued in on that would increase the patient's risk of future ICH?  Dr Ziai: In the past, what we're looking for really is markers of cerebral amyloid angiopathy, which significantly increase a person's risk for lobar hemorrhage in particular. And so, we have a set of criteria called the Boston Criteria, and there's a new version of these, version 2.0. And these, um, incorporate a number of imaging markers that provide a very high sensitivity and specificity to diagnose CAA after an ICH. But even if someone's never had an ICH, and they evaluate that risk-benefit ratio for different cardiovascular prevention strategies. And so, the markers that we're specifically interested in are, of course, microbleeds. But not just having microbleeds, but are they lobar or are they deep? Lobar having a higher risk for lobar ICH. How many microbleeds are there? Is it greater than five, or is it just one or two? Also, cortical superficial siderosis is a marker, a hemorrhagic marker, that does portend a significant increased risk of recurrent ICH, along with having a lobar ICH. And now we have these new markers, which are the white matter hyperintensity multi spot pattern, which requires these hyperintensities on flare imaging in the subcortical area, having greater than at least ten of these multi spots, and also having enlarged perivascular spaces in the centrum semiovale, and having at least twenty of those. And finally, white matter hyperintensities, which can be measured with the physica score or just by visualizing them. We can look at white matter hyperintensities as well as being a measure of small vessel disease.  Dr Albin: Got it. And so just to summarize, we're looking for small vessel disease markers because that puts our patients at higher risk of ongoing future bleeds. And then we're also looking for markers of particularly small vessel disease that's caused by cerebral amyloid angiopathy, which again, because it's having that protein deposition, that puts the patient at risk of those leptomeningeal very small vessels, putting the patient at risk of lobar ICH. Just confirming I've summarized this all correctly.  Dr Ziai: Yes. That was perfect.  Dr Albin: Amazing. Dr. Shah, I'm gonna go back to you. Let's say we have a patient. Let's say this is a sixty-five-year-old man who comes in and they want follow-up and they're... And you're trying to think about they've had an ICH in the past, and they are also at risk for ischemic disease. Let's say they, they have hypertension, they've had a smoking history. They have some risk for ischemic events. And you're trying to think about how do you balance those. Let's say the patient needs to be on aspirin but does have some of those high-risk features on their MRI. Is there any guidance on how we think through preventing them from having a recurrent bleed if they're a high-risk patient, also preventing them from having an ischemic event, which they might be at high risk for as well?  Dr Shah: Yes. So, I think, you know, the first step is of course trying to understand what was the type of bleed. I think that has a very important role, like you mentioned. If it's a lobar hemorrhage versus a deep hemorrhage, the risk of recurrent ICH and ischemic events is very variable. So lobar hemorrhages, there's obviously a higher risk of recurrent hemorrhage events, whereas deep hemorrhage is actually at or behaves sort of like small vessel ischemic strokes and have a higher risk of recurrent arterial ischemic events. So that distinction in itself can help you gauge which patients would be safe and would benefit from these therapies. To begin, and of course, looking for some of these markers on MRI that were mentioned by Dr. Ziai for recurrence of hemorrhage risk. In terms of antiplatelet, the, there is a lot more data now to guide treatment, and we have the RESTART as well as the ESTART trial that showed that starting an, a single antiplatelet after intracerebral hemorrhage did not increase the risk of hemorrhage recurrence. They were very variable in the timing when aspirin was started, and so that remains still a question about what is the safest time point to start aspirin. For example, in the ESTART trial, they started them very early, within the first three days, whereas in  the RESTART it was all the way up to two months after the hemorrhage. And so... But in general, the risk of recurrent ICH was very low with a single antiplatelet agent. And so, if it's needed for ischemic prevention, it's relatively safe broadly across all types of hemorrhages.  Dr Ziai: Yeah. I would just mention that there was also a subgroup analysis of the RESTART trial using MRI. And so, this more than likely included patients with CAA, since 40% of the hemorrhages were lobar in that study, and therefore seeing that there was no increased risk of recurrent ICH in RESTART, it is thought that putting patients back on their antiplatelet therapy is safe.  Dr Albin: That's a really huge takeaway pearl for our listeners, that regardless of whether it's a lobar bleed or a deep bleed, if there is a strong indication, you know, this is not just, oh, because someone gave them aspirin 81, but truly that there is a reason that they need to be on a single antiplatelet agent, it probably benefits them to be on that agent, and there's good data that there's not a huge increase in risk. Summarizing all of that?  Dr Ziai: Great.  Dr Albin: Now, things are gonna get a little bit tricky here, because what if the patient, what if they need to be on dual antiplatelet therapy? Or what if they need to be on anticoagulation? Dr. Ziai, I'll, I'll throw that to you. How do you tackle that patient population?  Dr Ziai: Yeah, the safety of dual antiplatelet therapy hasn't really been studied in patients who've had a prior ICH. Although, in people who've had previous strokes, putting them on dual antiplatelets doesn't seem to increase the risk of ICH, but it does increase extracranial hemorrhage. And so there may be other reasons not to put patients on dual antiplatelet agents. Patients who have cancer and also cardiovascular or cerebrovascular disease, putting them on dual antiplatelet therapy does seem to increase the risk for intracranial hemorrhage. So, I think there is enough of a bias against DAPT therapy in patients who have had an ICH that we would not recommend DAPT for patients with a prior ICH.  Dr Albin: Absolutely. And, and then what about, let's say they have atrial fibrillation, and you know that they have a high CHA2DS2-VASc score, and they are at very high risk of ischemic events, but they've also had a prior intracerebral hemorrhage. Walk us through a little bit, how should we approach that patient? Dr. Ziai, I'm gonna start with you again.  Dr Ziai: Sure. So again, looking at the MRI, which all patients with ICH should have nowadays. If patients do have these hemorrhagic findings, a lobar ICH, evidence of CSS, cortical superficial siderosis, especially if it's disseminated, and also lobar microbleeds, especially if there are greater than five, if they're multiple, then anticoagulation should really be avoided in those patients.  Dr Albin: Absolutely. So, I'm really hearing that when we have a patient with ICH, it is just critically important that we understand is this a hypertensive bleed or is this a lobar bleed that is probably related to cerebral amyloid angiopathy? And getting to that distinction is going to play a major role in our deciding whether or not the patient can be on DAPT or can be on anticoagulation. And then what are some of the strategies for patients that you're referring them to if they really cannot tolerate being on anticoagulation, but they have atrial fibrillation, and they do need some sort of ischemic stroke prevention?  Dr Shah: There's still a lot of controversy, even in non-lobar hemorrhages, about resuming anticoagulation and when that would be safe. HAF trial, there was a reduction in ischemic stroke recurrence, uh, but a significantly higher increase in hemorrhage recurrences. I think that trial included both deep and lobar hemorrhages. So, we still need more data, and I think the ASPIRE trial and maybe a meta-analysis would answer that eventually. But in the meantime, if a, specifically for lobar hemorrhages, which are, uh, thought to be CAA related, if they, uh, and the patient has AFib, you know, where anticoagulation would be contraindicated, a watchman device or, you know, AFib ablation may be some of the other strategies that can be looked into for those patients specifically.  Dr Albin: Right. I think that's a really important point to emphasize, that we don't just don't give up and say, "Oh, you're not a candidate for anticoagulation," but we really reach out to our cardiovascular friends and say, "Hey, what other procedures can you offer that will minimize the risk of recurrence?" You know, we don't want them to have an ischemic event, but we also know long-term that there would be a real risk of anticoagulation. Just reminder to our listeners that there are new procedures, and our cardiology colleagues are always doing new trials and new devices, and so we should really leverage their expertise here. I am in the final minutes gonna just switch gears a little bit from talking about sort of the nitty-gritty of secondary ischemic prevention and secondary hemorrhagic stroke prevention and thinking about there has been this degree of pessimism around ICH patients, and that, you know, they have a much more severe outcome than our patients with ischemic strokes. I think that that is probably a myth that we need to do some debunking around, and I think maybe we need to reframe in terms of thinking about just the trajectory. So, Dr. Shah, walk us through a little bit about what we can expect about the recovery trajectory in ICH compared to those patients who have an ischemic stroke. Dr Shah: Yes. From some newer data and studies, it is becoming clear that recovery after ICH is much slower than we expect. In general, for ischemic stroke, recovery is measured within the first few weeks to up to 90 days. But in ICH, we now know that patients can keep recovering all the way up to six months and even beyond. In general, from just a, a study of heart recovery that occurs after ischemic stroke, there's a steep recovery in the first seven days, and then sort of after that, patients still continue to recover, but it, it starts plateauing where up to 90 days. Whereas with ICH, there is not much recovery in the first 7 to 30 days, but after that, there is a recovery that occurs significantly between day 30 and day 180, and then some patients continue to recover all the way up to one year. The more severe the hemorrhage, the slower the recovery, but there's still some evidence to suggest that even severe hemorrhage patients can recover all the way up to one year out and beyond. This is, of course, in terms of functional recovery.  Dr Albin: I think that's a really important point for our audience. Many of the listeners are residents, they're fellows, they're seeing these patients in the hospital, and they may not see a whole lot of improvement over even 30 days. But to keep in mind that just because the patient has not had a dramatic recovery within that first month that they may be in the ICU and then on the floor does not mean that that patient will never have recovery, and that we reset our expectations that recovery is possible, it's just gonna be slower. And I think that that's not only important for the healthcare team to take in mind, but also for patients and their families to know there is hope here. It's just gonna be slower. Dr. Ziai, looking ahead, what developments in this are you most excited about that you think will move the needle for care for the long-term outcomes and the prevention for these patients? What's ahead in, in ICH?  Dr Ziai: Yeah, I think the research that's going on is very exciting at the moment. We just saw the presentation at the World Stroke Organization conference in the fall of the TRIDENT trial, Triple therapy prevention of Recurrent intracerebral Disease events, meaning strokes. And these investigators found that a single pill, a fixed dose of three blood pressure-lowering agents actually was successful in significantly reducing the risk of recurrent stroke in patients who have had a history of ICH and have just normal or low-grade hypertension. So rather than having patients on multiple antihypertensive agents, it may be possible to have them on a single pill, and may dramatically reduce their stroke risk. So that's exciting. There is also a trial ongoing, ASPIRING, testing whether antiplatelet monotherapy after 24 hours only can reduce the risk of all serious vascular events in ICH survivors. So very early antiplatelets. The SATURN trial, we didn't talk about statins yet, but it is comparing continuation versus discontinuation of statin therapy in ICH patients. And then we have ongoing epidemiological studies that are really needed to understand this interaction between the cardiovascular prevention strategies, the antithrombotic use, the blood pressure targets, and these high-risk neuroimaging markers for ICH. And I think that's gonna be key, personalizing the interventions for these patients.  Dr Albin: So, I love that. And what I'm hearing is that it's really important to think about the personalized approach as well as how do we simplify things. We know that blood pressure control is critically important to the primary and secondary prevention of ICH, but we have to make it easy for patients to do so. Dr. Shah, I want to end with kind of understanding, you know, this was an unusual topic for neurointensivists to talk about. This was really about prevention. It was about long-term survivorship. It was about not what's happening in the neuro ICU. How did you guys get interested in sort of that aspect of care?  Dr Shah: Yeah, so that's a great question. Dr. Ziai has been my mentor since I was in fellowship, so now about eight years that I've been working with her, and this was a project that I started in fellowship with under her mentorship, looking at long-term recovery in ICH patients, and specifically severe patients. Happy that work has received a lot of recognition. It was published in JAMA Neurology. We looked at patients with severe intracerebral and intraventricular hemorrhage, those that survived with an mRS of four and five at day 30, and what happened to them over the course of the year. There was really not much data on recovery after ICH. And we were very surprised to see that up to 40% of patients that were an mRS of four and five, so really, really severely disabled at day 30, recovered to an mRS of zero to three by one year. About one-third of that group that recovered actually achieved functional independence with an mRS of zero to two, which was very surprising, really breaking the myths around the pessimism with ICH. We found that a lot of the baseline comorbidities like diabetes, white matter disease, as well as what happens to them during the acute hospitalization, were adding all of that information to the severity of the hemorrhage significantly improved our ability to predict long-term recovery after ICH. And so that's kind of how we got interested in this work, looking at how factors in the care that we provide in the ICU, as well as what the patients come in with, how all of that could be modified to promote recovery in these patients that are often been forgotten.  Dr Albin: I think that there's one takeaway to our listeners is that this is really a place where there's a lot of hope for recovery, and that the nihilism that has really surrounded ICH is a thing of the past, and we have to move forward with thinking about how do we proactively impact the recovery and counsel the patients and give them hope. Because just as your research shows, there really is the ability that they can attain that functional independence, which is absolutely astounding. It's really amazing. Again, today I've been interviewing Dr. Wendy Ziai and Dr. Vishank Shah about their article on intracerebral hemorrhage. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Please be sure to check out Continuum Audio episodes from this and other issues. Please go and check out. They have a wonderful article with lots of tables and figures, so much data. And again, thank you to our listeners for joining us today. Thank you, Dr. Ziai and Dr. Shah.  Dr Ziai: Thanks very much.  Dr Shah: Thank you.   Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

What if you could do a beautiful class four in the same 30 minutes you'd spend on a regular filling? In this episode, Dr. Reza Ardalan sits down with Dr. Susan McMahon, an AACD-accredited restorative dentist out of Pittsburgh and one of the most recognized clinicians in the country. Susan is the founder of Smiles in the City, a fee-for-service restorative practice she built from the ground up after starting her career in a drill-fill-and-bill amalgam office. The conversation takes a personal turn early when Susan tells the story of the $100,000 laser whitening system she signed up for without reading the contract — the moment her practice tipped from "what people need" to "what people want." From there, Reza and Susan go everywhere: why AACD accreditation rebuilds your eye, how she became a restorative referral source for teenagers and post-ortho cases, the conservative European mindset she picked up training in Italy, why diastema closure and class four restorations can be done predictably in the same time as a regular filling, and the tag-the-practice social media system that fills her chair. A key part of the conversation lands at the end. Susan walks Reza through her upcoming online restorative course — five one-hour modules built for general dentists who want to elevate their everyday restorations without slowing down their day. Module one is the class four. Module two is the invisible class three (no gray, no lost sheen). Module three is her five-minute finish — the polish that puts surface anatomy back so composite reads as enamel instead of plastic. Module four is using provisionals as the prototype for final restorations. Module five covers her full enamel treatment toolkit — microabrasion, infiltration, whitening combinations. It's the first time she's put her actual restorative system online, and if you've ever felt the gap between what you see on social media and what you can actually produce in your operatory, this one is gold. Key Points The $100,000 laser whitening machine she signed for without reading the contract — and why it changed her career Why a beautiful class four takes the same 30 minutes as a regular class four — if you know the system The invisible class three: how to finish without gray shadow or lost sheen Using provisionals as the prototype for final restorations — the move most GPs skip The full enamel treatment toolkit: microabrasion, infiltration, and whitening combinations Why AACD accreditation is closer to a board exam than a CE certificate How she became a restorative referral source for teenagers coming out of ortho Why 40% of clear orthodontic cases finish with black triangles What four trips to Italy taught her about being conservative with the drill Dr. Susan McMahon is a clinician and educator whose teaching focuses on conservative techniques that preserve natural tooth structure. She lectures internationally on minimally invasive cosmetic and restorative work, sharing the techniques she uses in her own practice with general dentists worldwide. As an Accredited Member of the American Academy of Cosmetic Dentistry, Fellow of the American Society for Dental Aesthetics, and Fellow of the Academy of General Dentistry, Dr. McMahon leads one of Western Pennsylvania's premier cosmetic dental practices. She has been named a Top Dentist more than 20 times, including consecutive annual selections as a Top Pittsburgh Dentist by her peers for more than two decades. Find Dr. McMahon on Instagram at @smilesinthecity and @DrSusanMcMahon. Learn more about Zero Trace Restoration on Dental Education Studios. Five techniques that make everyday restorations look like advanced esthetic dentistry — built around systems any general dentist can run in their existing appointment blocks. The course starts on Tuesday, Sept. 15th. Join live or watch the on-demand recordings.

In Episode 2 of our series on Postural Orthostatic Tachycardia Syndrome (POTS), we focus on evidence-based treatment strategies to help children and adolescents manage symptoms and improve daily functioning. Our guest reviews the foundation of POTS management, emphasizing lifestyle interventions such as maintaining adequate hydration, increasing salt intake when appropriate, establishing healthy sleep habits, and implementing a gradual, structured exercise program.The discussion also explores the role of nutrition, compression garments, and heat avoidance in reducing symptom burden, along with practical accommodations that can support patients at school and in everyday activities. Finally, we review pharmacologic treatment options, discussing when medications may be appropriate and how they fit into an individualized care plan. Throughout the episode, the emphasis is on developing a comprehensive, patient-centered approach that helps children and adolescents regain function and improve their quality of life.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dr. Linda Chu speaks with Dr. Eddy Zandee and Dr. Kirk Davis about multidisciplinary expert consensus recommendations aimed at reducing the use of low yield radiographs and improving imaging appropriateness across healthcare settings. They explore which common radiographic exams may offer limited clinical value, when CT or MRI may be more appropriate, and how education and workflow changes can help optimize imaging utilization. Optimizing Radiography Utilization: Multidisciplinary Expert Consensus Recommendations Endorsed by the Society of Academic Bone Radiologists, Society of Skeletal Radiology, American Societyof Emergency Radiology, Orthopaedic Trauma Association, American Academy of Emergency Medicine, and American Rhinologic Society. Zandee van Rilland et al. Radiology 2026; 319(2):e252309.

Looking for proven ways to end bullying in your unit? Join the co-hosts as they welcome expert Renee Thompson for a candid, practice-focused conversation on bullying in the nursing workforce. Renee will also be presenting the keynote presentation at the 2026 AMSN Convention in September.     To learn more about the 2026 AMSN Convention OR to register, visit: https://amsn.org/Events/AMSN-Convention   SPECIAL GUEST   Dr. Renee Thompson, DNP, RN, FAONL, FAAN, CSP is CEO & Founder of the Healthy Workforce Institute®. She is a sought-after speaker, bestselling author, consultant, and leading authority on creating healthy workforces by eliminating bullying and incivility. With over 30 years of experience as a clinical nurse, nurse educator, quality manager, and nurse executive, Dr. Thompson spends the majority of her time working with healthcare leaders who want to cultivate a healthy workforce. Renee is the CEO and Founder of the Healthy Workforce Institute and has been repeatedly published, interviewed, and awarded for her work to eradicate disruptive behaviors in healthcare. In 2020, Renee was invited by the Joint Commission to become a member of their Workplace Violence Technical Advisory Panel, has been published in numerous nursing journals, and is a frequent invited guest on radio, podcasts, webinars, and online social media platforms. In 2016, Renee received the Nursing Excellence award as a nurse entrepreneur, honoring her work to eliminate workplace bullying. She received the first Outstanding Nursing Alumni for Excellence in Leadership Award and Distinguished Alumni recognition from her alma mater, and was a finalist in the Healthcare Heroes Awards as a Healthcare Provider. Her blog has won numerous awards as a Top Nursing Blog "must-read" by the online nursing community, and her anti-bullying videos are viewed by healthcare organizations around the world. Renee is one of only 30 nurses in the world who have achieved the prestigious Certified Speaking Professional designation. In 2018, she was recognized as one of LinkedIn's Top Ten Voices in Healthcare for her contribution to their global online healthcare community and in 2022 was identified as one of the top 5 Nurse Influencers on LinkedIn. Also in 2022, Renee was inducted as a Fellow of the American Academy of Nursing for her work to eradicate disruptive behaviors in healthcare and in 2024 received the Safe Spaces award from the Florida Nurses Association. In March 2026, Renee will be inducted as a Fellow of the American Organization for Nursing Leadership for her sustained contributions to the specialty of nursing leadership, commitment to service and influence in shaping health care by addressing disruptive behaviors. Renee has a Master's degree in Nursing Education and a Doctorate of Nursing Practice from the University of Pittsburgh.   MEET OUR CO-HOSTS Kellye' McRae, MSN-Ed, RN is a dedicated Med-Surg Staff Nurse and Unit Based Educator based in South Georgia, with 12 years of invaluable nursing experience. She is passionate about mentoring new nurses, sharing her clinical wisdom to empower the next generation of nurses. Kellye' excels in bedside teaching, blending hands-on training with compassionate patient care to ensure both nurses and patients thrive. Her commitment to education and excellence makes her a cornerstone of her healthcare team.   Marcela Salcedo, RN, BSN is a Floatpool nightshift nurse in the Chicagoland area, specializing in step-down and medical-surgical care. A member of AMSN and the Hektoen Nurses, she combines her passion for nursing with the healing power of the arts and humanities. As a mother of four, Marcela is reigniting her passion for nursing by embracing the chaos of caregiving, fostering personal growth, and building meaningful connections that inspire her work. Hayley Sweetser, MSN, APRN, AGCNS-BC, MEDSURG-BC, CPHQ, WTA-C is a Clinical Nurse Specialist in Newark, Delaware who provides support to patients and caregivers within the Acute Medicine Service Line at ChristianaCare. She is working towards reducing overall patient harm events within the service line through collaboration with bedside nurses, physicians, and other specialties. Hayley has a strong passion for medical-surgical nursing and has spent her whole nursing career in this specialty. She strives to advance medical-surgical nursing practice by encouraging alignment with evidence-based practice.   Eric Torres, ADN, RN, CMSRN is a California native that has always dreamed of seeing the World, and when that didn't work out, he set his sights on nursing.  Eric is beyond excited to be joining the AMSN podcast and having a chance to share his stories and experiences of being a bedside medical-surgical nurse.   Sydney Wall, RN, BSN, CMSRN has been a med surg nurse for 5 years. After graduating from the University of Rhode Island in 2019, Sydney commissioned into the Navy and began her nursing career working on a cardiac/telemetry unit in Bethesda, Maryland.  Currently she is stationed overseas, providing care for service members and their families.  During her free time, she enjoys martial arts and traveling.  Trish West, DNP, MSN, CMSRN, PCCN, CEN, NEA-BC, FAMSN is a passionate nurse leader whose career reflects both expertise and a heartfelt commitment to advancing patient care. Trish's credentials include being a Certified Medical Surgical Registered Nurse, Progressive and Emergency Nursing, Nursing Executive Advanced, and most recently, induction as a Fellow in the Academy of Medical Surgical Nursing. She enjoys spending time with her husband Mark and their five children. Her favorite motto, "Never underestimate the difference you can make," truly captures the spirit with which Trish approaches both professional and personal endeavors.   

The Pediatric Lounge PodcastEvidence-Based Pediatric Office Emergency Preparedness: Practical Implementation and Real-World DebateHosts: Dr. Herb Bravo & Dr. George RoguGuests: Dr. David Mathison & Dr. Seth TobackIn this episode of The Pediatric Lounge, hosts Dr. Herb Bravo and Dr. George Rogu welcome Dr. David Mathison, Senior Vice President of Clinical Performance at PM Pediatrics, and Dr. Seth Toback, Chief Medical Officer at ARMR Science, for a timely discussion on evidence-based pediatric office emergency preparedness.The conversation explores the American Academy of Pediatrics' 2026 Technical Report, which updates and replaces the 2007 guidance on office emergency preparedness. Together, the panel examines how pediatric practices can translate evidence into practical workflows while balancing patient safety, costs, staffing realities, and the diverse environments in which pediatricians practice.Dr. Toback also discusses the science behind ARMR Science's investigational fentanyl conjugate vaccine, its potential role in addressing the opioid crisis, and the populations that may benefit if future clinical studies prove successful.The discussion focuses on preparing pediatric practices for the emergencies they are most likely to encounter—including respiratory distress, seizures, anaphylaxis, behavioral health crises, and diabetic emergencies—while emphasizing rapid recognition, stabilization, activation of EMS, structured communication during patient handoffs, defined team roles, simulation-based training, and continuous quality improvement through post-event debriefing.The panel also explores:How evidence should guide recommendations for office emergency preparednessWhether "essential" equipment recommendations should vary by practice settingThe costs, return on investment, and potential liability associated with emergency equipmentThe role of AEDs, CPR, PALS, and ACLS training in outpatient pediatric practicesWhy simulation training may be more effective than traditional mock codesRecognition skills for front-office staff and non-clinical personnelAppropriate stocking of emergency medications, including naloxone and epinephrineInnovation gaps in pediatric emergency preparednessThe growing challenge of pediatric behavioral health emergenciesCreating practical, scalable guidance for practices of every sizeWhether you are a solo pediatrician, part of a large health system, or responsible for quality improvement within your organization, this episode provides a thoughtful discussion of how to build an emergency preparedness program that is evidence-based, sustainable, and realistic.Episode Chapters00:00 — Introduction and Guest Welcome02:24 — Why Dr. Mathison Chose Pediatrics04:18 — Understanding the Fentanyl Vaccine05:56 — Dr. Mathison's Journey at PM Pediatrics08:40 — The Biggest Challenges Facing Pediatrics Today11:46 — Training Gaps and Effective Patient Handoffs15:02 — Reviewing the 2026 AAP Emergency Preparedness Guidance20:48 — The Debate: Practical Office Emergency Preparedness32:28 — Mock Codes vs. Real-World Readiness38:45 — Why Simulation Training Matters40:33 — Gaps in Current Training Standards42:15 — Teaching Front Desk Staff to Recognize Emergencies45:10 — What Every Office Should Stock—and What It Can Skip47:25 — Naloxone, Epinephrine, and Medication Preparedness50:32 — AEDs: Liability, Cost, and Return on Investment55:33 — The Public Health Role of Pediatric Practices58:03 — Should Offices Maintain ACLS Skills?1:03:40 — Developing Right-Sized Guidance for Every Practice1:06:22 — Debriefing, Continuous Improvement, and Future Updates1:10:59 — Final TakeawaysSupport the show

Because of the US's war with Iran, people around the world are experiencing food and price shocks. On today's show, guest host Patty Peltekos is in conversation with environmental historian Kate Brown, author of the new book Tiny Gardens Everywhere: The Past, Present, and Future of the Self-Provisioning City, to talk about how people living in cities can contribute to their own food sovereignty.  Modern zoning laws too often prevent people from creating gardens in cities. Brown talks about how it once was: people farming the commons using what we would now call regenerative agriculture. That was before the invention of private property, consumer culture, and the enclosure movement in Europe that transformed land and labor. But people are pursuing tiny gardens as an antidote to industrial agriculture. From Washington, DC to Berlin, Brown profiles the ingenious ways people are growing tomatoes instead of turf grass, defying unjust laws, and sharing their bounty with neighbors. And states as different as Maine and Florida are creating legislation to make it easier for people to create their own tiny gardens.  If you want to start gardening, Brown says the first thing to do is find a friend to garden with. They also talk about migrant labor in the US, how Brown decolonized her research, and how industrial equipment, fertilizers, and insecticides are waging war on the environment. Kate Brown is the Thomas M. Siebel Distinguished Professor in the History of Science at the Massachusetts Institute of Technology. She is the author of several prize-winning histories, including Plutopia: Nuclear Families in Atomic Cities and the Great Soviet and American Plutonium Disasters (Oxford 2013) and A Biography of No Place: From Ethnic Borderland to Soviet Heartland (Harvard 2004). Manual for Survival: A Chernobyl Guide to the Future (Norton/Penguin Lane, 2019), translated into eight languages, won the Marshall Shulman and Reginald Zelnik Prizes for the best book in East European History, plus the Silver Medal for Laura Shannon Book Prize. It was also a finalist for the 2020 National Book Critics Circle Award, the Pushkin House Award and the Ryszard Kapuściński Award for Literary Reportage. Brown was a Guggenheim Fellow in 2009, a Carnegie Fellow and winner of the American Academy's Berlin Prize in 2016. Her latest book, Tiny Gardens Everywhere: The Past and Present of Urban Self-Provisioning was published by Norton in February 2026. Brown's work on Tiny Gardens has been supported by fellowships from the National Endowment for the Humanities and the Netherlands Institute for Advanced Studies. She has published a short segments from this work in the New Yorker, Mother Jones and Lithub. Featured image of the cover of Tiny Gardens Everywhere: The Past, Present, and Future of the Self-Provisioning City. Did you enjoy this story? Your funding makes great, local journalism like this possible. Donate hereThe post What If Urban Gardeners Could Feed Us? appeared first on WORT-FM 89.9.

This week on Dentistry Unmasked, Pam and Brian sit down with Dr. Mia Geisinger, past president of the American Academy of Periodontology, for a powerful conversation about the undeniable connection between oral inflammation and systemic health. For too long, “a little bleeding” has been minimized or accepted as normal—but Dr. Geisinger makes it clear: bleeding is a sign of inflammation, and inflammation matters. With dozens of systemic illnesses linked to or exacerbated by periodontal inflammation, dental professionals have a critical opportunity to help patients understand that periodontal health is not just about saving teeth—it is about supporting whole-body health. In this episode, Dr. Geisinger breaks down the science, the responsibility, and the opportunity we have as clinicians to collaborate with our patients, improve periodontal outcomes, and reduce the oral inflammatory burden that may contribute to systemic disease. If you have ever struggled to get patients to take bleeding gums seriously, this conversation will give you the language, confidence, and clinical perspective to change the way they see their oral health.Tune in for a compelling episode that reminds us why periodontal health is no longer optional—it is foundational.

Susan Guthrie turns to a subject that keeps more people up at night than almost any other one in divorce: money. Specifically, how to protect it, and how to stop spending it in the wrong places. Heather Locus is a CPA, certified financial planner, and certified divorce financial analyst with a rare gift for taking the most complicated financial pieces of divorce and making them feel manageable. In this episode, Heather shares her top strategies for saving money in your divorce, from the common mistakes that quietly drain your settlement to the smart moves that keep more of your hard-earned dollars where they belong, with you. Together, Susan and Heather walk through her five ways to save money in a divorce, from getting organized early and assembling the right support team, to keeping business and emotion separate, to using her Settle Smart projections to see the road ahead. As Heather points out, these are critical points whether you have millions in the bank or are living paycheck to paycheck. What You'll Learn Why something as simple as setting up a separate email for divorce communications can save real time, money, and stress What discernment counseling is, and how pausing to consider it can save money in your divorce negotiations, even if you still end up divorcing Why having laser focused priorities, for yourself and for your spouse, is the key to smart negotiating How to assemble the right support team, and when mediation, collaborative divorce, or traditional litigation is the better fit Why remembering "it's business" helps you make financial decisions instead of emotional ones What Settle Smart is, and how modeling your financial future helps you know what to accept, and what's worth continuing to negotiate for Episode 3 of 8 in the Divorce & Beyond Summer Essentials Series. This summer, Divorce & Beyond brings back 8 the episodes listeners reach for most, the conversations with the clearest, most practical guidance for anyone thinking about, going through, or rebuilding after divorce. New Essentials air every other Monday all summer. Follow the show so you never miss one.  About this week's special guest: Heather Locus Heather founded the National Divorce Practice Group at BDF Private Wealth to help divorcing individuals consciously navigate their divorce's emotional and business aspects. From hiring the right fit attorney through their SettleSmart™ analysis, then implementing the divorce decree and auditing it annually, Heather ensures you have the resources you need to start your next chapter on a firm footing. Heather founded our Women's Service Team in 2006 to help female executives and business owners, widows, and women transitioning through divorce. After going through her own divorce in 2011, she realized how much more we could do to support divorcing women and men with a practice dedicated to serving their unique needs. Heather is driven by deep empathy to help divorcing individuals have clarity and confidence in finalizing their divorce. A Forbes “America's Top Women Advisor,” Heather is a nine-time “Five Star Wealth Manager” according to Chicago magazine, was named an “Influential Women in Business” by The Business Ledger, a “Top 200 Wealth Advisor Mom” by Working Mother, and an InvestmentNews “Woman to Watch.” Heather is an author of two books on divorce and has contributed to leading publications, including The Wall Street Journal, Crain's Chicago Business, Family Lawyer Magazine, and Divorce Magazine on multiple topics. She is a CPA, CFP® practitioner, and a Certified Divorce Financial Analyst (CDFA®) professional and has completed intensive executive coaching and divorce mediation training. Heather loves learning from her teenage son and daughter and working with organizations she is passionate about, including After School Matters, The Lilac Tree, Between Friends, and Make-A-Wish Foundation. For more information on Heather: Call/Text Heather at 312-312-2144 or email hlocus@bdfllc.com if you or a friend are contemplating or in the middle of a divorce. Financial Issues in Divorce: A Client Handbook: Heather's latest book written for the American Academy of Matrimonial Attorneys. Listen to Heather's prior episode of Divorce & Beyond:   Negotiating Your Financial Future: Key Factors to Consider with Leading Divorce Financial Professional, Heather Locus" on The Divorce & Beyond Podcast with Susan Guthrie, Esq. #114 If This Episode Helped You Follow Divorce & Beyond so you never miss an episode. Share it with someone who needs clear, reliable guidance right now. And if you have a moment, a five-star review makes a real difference in helping the show reach the people who need it most. Follow Divorce & Beyond Website: divorceandbeyondpod.com Instagram: instagram.com/divorceandbeyondpod About the Host: Susan Guthrie, Esq. Susan Guthrie is one of the nation's leading family law and mediation attorneys, with more than 35 years of experience helping people navigate divorce with clarity and strategy. She is the Immediate Past Chair of the American Bar Association Section of Dispute Resolution, a best-selling author, and a sought-after speaker and trainer. Susan recently appeared as the featured expert on The Oprah Podcast and has been cited in The Wall Street Journal, Forbes, Town & Country, The Washington Post, NewsNation, and NBC Chicago Today, among others. As the creator and host of Divorce & Beyond, ranked in the top 1% of all podcasts worldwide with more than 1.3 million downloads and an Apple Top 100 Self-Help designation, Susan brings together leading legal and mental health experts to help listeners move through divorce and into what comes next. Learn more at divorceandbeyondpod.com/about.   Disclaimer: The commentary and opinions shared on this podcast are for informational and entertainment purposes only and do not constitute legal advice. Consult a licensed attorney in your state regarding your specific situation.  

What does it really look like to help your child build a healthy relationship with food? In this episode, Dr. Emily tackles one of today's biggest parenting challenges—raising healthy eaters in a culture that often confuses health with dieting. Her message is simple: "We really don't want our kids dieting." Instead of focusing on restriction, she shares practical, evidence-based habits that help children develop lifelong healthy relationships with food. Drawing insights from the American Academy of Pediatrics book Your Child Is Not Their Weight, Dr. Emily explains why parents should focus less on perfect meals and more on consistent family habits. She discusses the importance of offering a variety of foods, keeping regular meal and snack times, avoiding food as a reward, and creating distraction-free family meals where children can learn to listen to their own hunger and fullness cues. Throughout the episode, Dr. Emily reminds parents that "you control what comes into the house, and your child controls how much they eat." Rather than becoming a "short-order cook," she encourages families to serve one meal, include at least one familiar food for picky eaters, and allow children to explore new foods without pressure. She closes with three powerful reminders that have made the biggest difference in her own family: Prioritize family meals. Help children recognize physical hunger instead of emotional hunger. Keep a variety of healthy foods available and lead by example. As Dr. Emily says, "If you can start to demonstrate a healthier relationship with food, they're going to pick up on it." Small, consistent changes today can shape a lifetime of healthy habits for your children.

In a world so fraught with chaos and uncertainty, where can we find connection and hope? Author Terry Tempest Williams invites readers to learn about what she calls "The Glorians." In her latest work, The Glorians: Visitations from the Holy Ordinary, Williams explains that Glorians are not distant deities, but instead ordinary, often overlooked presences — animals, plants, memories, moments — that reveal our shared vulnerability and interconnectedness with the natural world. The Glorians can be as small as an ant or as commonplace as the night sky. Williams offers both personal and societal insight in her assertion that Glorians have much to teach and remind us about consciousness, connection, and courage. In pages that explore subjects like climate change, finding wonder in the unexpected, and turning to deep reflection and intention, The Glorians invites us to imagine a better and more beautiful future in a time of uncertainty. Terry Tempest Williams is the award-winning author of seventeen books of creative nonfiction, including the environmental classic, Refuge – An Unnatural History of Family and Place. Among her other books are Leap, Finding Beauty in a Broken World, When Women Were Birds, The Hour of Land – A Personal Topography of America's National Parks, and Erosion – Essays of Undoing. Her work has been translated and anthologized worldwide. She is a member of the American Academy of Arts & Letters and is currently the writer-in-residence at the Harvard Divinity School. She divides her time between Cambridge, Massachusetts and Castle Valley, Utah. Buy the Book The Glorians: Visitations from the Holy Ordinary Elliott Bay Book Company

Lessons from a Lost Republic: What Ancient Rome Can Teach Us About This American Moment by Michelle Berenfeld https://www.amazon.com/Lessons-Lost-Republic-Ancient-American/dp/1966302215 Michelleberenfeld.com A lively pocket history of the Roman Republic's collapse—and its unsettling echoes in our own political moment. Americans are obsessed with Rome. Billionaires and manosphere pundits wax on about its military might, its gladiators, its emperors, its greatness. But we're telling ourselves the wrong story. In this sharp, eye-opening account, classics professor Michelle Berenfeld redirects our gaze. The Roman Empire isn't the lesson—the Roman Republic is. Nearly five centuries of representative government, undone by forces that should sound familiar: wealth and power concentrated in the hands of elites, rampant political violence, endless expansionist wars, and a Senate that normalized emergency measures until it had nothing left to protect. One by one, aspiring strongmen seized what the Senate had surrendered, stretching the limits of their legal power, using the military against their own people, undermining elections, and killing their enemies—until one of them, Augustus, gained total control and became an emperor. Berenfeld's argument is both clarifying and urgent: Rome's slide into autocracy was not inevitable—and neither is ours. Smart, spirited, and packed with revelatory detail, Lessons from a Lost Republic is a wake-up call two thousand years in the making, a reminder that the republic is ours to protect. About the author Michelle Berenfeld is the John A. McCarthy Professor of Classics at Pitzer College, one of the Claremont Colleges. An archaeologist and fellow of the American Academy in Rome, she has done research in Turkey, Jordan, Egypt, Greece, and Italy. Her work has appeared in The Atlantic and numerous scholarly publications. She lives in Los Angeles.

Your eye color can change your day-to-day comfort in sunlight and it can hint at different long-term risks, but the real story is melanin. I'm Dr. Mark Grossman, an integrative medical optometrist and licensed acupuncturist, and I walk through what melanin is, how it functions as a natural pigment inside the eye, and why it acts like an internal shield against harmful light.We connect the science of eye pigment to practical outcomes: why darker eyes often block more UV and reduce internal glare, why lighter eyes can experience more light scatter and photophobia, and what that can mean for macular degeneration risk. We also discuss a noteworthy tradeoff mentioned by the American Academy of Ophthalmology about dark eyes and a slightly higher cataract risk, plus the higher risk of ocular uveal melanoma (a rare eye cancer) associated with lighter irises.From there, we get concrete about natural eye care and prevention. I explain melanin's protective roles like absorbing UVA and UVB radiation, helping stabilize free radicals, and filtering glare across the retina. Then we shift into what you can control today: wearing 100% UV-blocking sunglasses, using a wide-brimmed hat outdoors, and even looking into melanin-based sunglasses, which block 100% of UVA/UVB rays and filter High-Energy Visible (HEV) blue light. Finally, we review nutrients and herbs that may influence our ability to build melanin, including green tea, turmeric, ginseng, lotus flour, fenugreek, and saffron, with a clear-eyed look at what's promising versus what's not yet proven.If you care about eye health, UV protection, and simple habits that support healthy vision, subscribe, share this with a friend, and leave a review. And, visit us at https://naturaleyecare.com/

A new 162-page report just released by the White House flags a museum exhibition for what it says is “radical, activist ideology” that “seeks to teach disdain and inspire disgust of our great country.” The report faults Native land acknowledgements, mentions of stolen land, and the use of the term “genocide” connected to an ongoing exhibition by the National Museum of the American Indian (NMAI). The report by the White House Domestic Policy Council argues leaders at the Smithsonian Institution have pushed an agenda of social justice advocacy instead of objective historical research. We'll talk with Native historians and curators about this new escalation of the Trump administration's drive to change existing narratives about Native history. GUESTS Suzan Shown Harjo (Cheyenne and Arapaho Tribes and Hodulgee Muscogee), a founding trustee of NMAI, recipient of the Presidential Medal of Freedom, and the first Native woman elected to the oldest learned societies in the U.S. – the American Philosophical Society and the American Academy of Arts and Sciences Rick Hill Sr. (Tuscarora), vice president of the Niagara Academy for Indigenous Relations Dr. Samuel Torres (Mexica/Nahua), deputy CEO of the National Native America Boarding School Healing Coalition Sierra Biidaaban Nadeau (Kchi Wiikwedong Anishinaabe), author of “What the Ancestors Say”, award-wining journalist, and reporting specialist for Miigwech Inc. Break 1 Music: War Dance Song 1 (song) Burton Fisher, George Fisher, Charles Little Oldman, & Clifford Bighead (artist) 12 Northern Cheyenne Songs (album) Break 2 Music: Medicine Wheel (song) Logan Staats (artist) Rainwater (album)

Stroke in children and younger adults differs significantly from adult stroke, with varied presentations and a broader range of underlying causes such as congenital heart disease and arteriopathies. This episode highlights key diagnostic considerations and evolving approaches to treatment in these younger populations. In this episode, Aaron L. Berkowitz, MD, PhD, FAAN, speaks with Thalia S. Field, MD, FRCPC, MHSc, coauthor of the article "Stroke in Children and Younger Adults" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology in the Department of Neurology at the University of California, San Francisco, in San Francisco, California. Dr. Field is a professor at the University of British Columbia and the Sauder Family Heart and Stroke Professor of Stroke Research, and a stroke neurologist at the Vancouver Stroke Program, Vancouver Coastal Health in Vancouver, British Columbia, Canada. Additional Resources Read the article: Stroke in Children and Younger Adults Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @AaronLBerkowitz Full episode transcript available here Dr Berkowitz: Most neurologists are used to evaluating and treating adults with stroke since it's one of the most common neurologic conditions. But stroke can also occur in children, in infants, and even in utero. Today, I have the privilege of interviewing Dr. Thalia Field to talk about pediatric stroke.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Berkowitz: This is Dr. Aaron Berkowitz, and today I'm interviewing Dr. Thalia Field about her article on stroke in children and younger adults. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast, Dr. Field, and could you please introduce yourself to our audience?  Dr Field: Well, thanks so much. It's a pleasure to, uh, be speaking to you. I'm a stroke neurologist, and I treat adults generally. My wonderful colleague, Thivya Selvanathan, who's a neonatal neurologist, co-wrote the chapter with me. We do, unfortunately, have to treat some children with stroke collaboratively and I do advise on those cases. My practice is about one-quarter clinical, so I treat patients with acute stroke, look after them on the wards, see patients in stroke prevention clinic, and the rest of my time is mainly research and some administrative work and teaching. I run the clinical trials program for the Vancouver Stroke Program, and I do research of my own, mainly focused on stroke in younger adults. We previously did a trial and registry on cerebral venous thrombosis, and more recently, I've been running a national study looking at brain health in adults and children with congenital heart disease.  Dr Berkowitz: Fantastic. Wow, that is a lot that you do, and we'll look forward to the results of some of those studies. So, when adults suffer a stroke, they typically present with sudden onset focal neurologic deficits, very common scenario we're consulted on.  And one thing you and your colleague talk about in the article is that strokes can present differently in infants and in young children. Can you talk a little bit about the differing clinical presentations of stroke in the youngest young as compared to our usual experience treating the older adults?  Dr Field: Sure. So, you know, speaking about this as someone who doesn't see the children directly but has had the opportunity to discuss these patients with my colleagues and, like we all do, learn about it during our training, I think one of the distinctions, especially with neonates, is that it's generally not a presentation with focal neurologic deficits. Often these babies will have seizures or encephalopathy as their main presentation, and sometimes we're only finding out after the fact if they're presenting with developmental delay or early preference for handedness and hypotonia, things like that. So, in very young children, that's a distinction. And in older children, there can be sudden onset deficits and, and unfortunately, sometimes these are mistaken for other conditions that are more common in children, like seizures. But sometimes you can have a more indolent course, say, with something like a focal cerebral arteriopathy or something like that. So, it depends on the scenario, but the big difference primarily is in neonates, as far as I understand.  Dr Berkowitz: Perfect. That's very helpful. So as an adult neurologist, when I think about causes of stroke or teach sort of the categories of causes of stroke to our residents and students, when we think about the evaluation of stroke, I divide them broadly into causes related to the heart, causes related to the blood vessels, and causes related to the blood with, in the adult world, the most common things, of course, being atrial fibrillation for the heart, atherosclerosis for the blood vessels, and then risk factors for atherosclerosis in the blood, diabetes, hyperlipidemia, very rarely picking up a hypercoagulable disorder in the blood column. And reading your article, it seems that, correct me if I'm wrong, stroke in young adults, stroke in the pediatric population can basically be organized into those same broad categories, heart, blood vessels, and blood, just that there's many more conditions on the differential diagnosis that you would consider in young adults to begin with and then children and then neonates as we get into the younger and younger population. So, I'd like to talk about each of these sort of buckets of etiology in turn and ask you about some of the causes we would consider in young adults and children in each of these, and then as they come up, probably ask you more questions about how frequently we find these sorts of things, how frequently they're the cause of stroke treatment, et cetera. So, let's start with the heart. As I said, in adults, we're mostly looking for rhythm disorders, right, atrial fibrillation. Sometimes we'll pick up a patent foramen ovale or PFO or other structural abnormalities, but mostly we're thinking about atrial fibrillation. But reading your paper, I was struck by the huge variety of conditions that you might be looking for in the heart in children or infants with stroke. So, can you tell us a little more about cardiac etiologies of stroke in the young?  Dr Field: Yeah. So, I'd say unlike in older adults, where it tends more often to be a rhythm disorder, in children and adults who are younger, it's primarily a structural cause, and congenital heart disease being the most common. And it changes a little bit from younger adults shifting downwards in age to younger children in terms of the fact that often if we're seeing an adult with stroke related to congenital heart disease, it can be a paradoxical embolism from a previously undiagnosed PFO. Not in all cases, but fortunately this is improving over time. You know, generally people with diagnoses of more severe congenital heart disease are followed up from childhood and people are aware of the diagnosis, and hopefully they're being managed and watched for things like premature arrhythmias or depressed heart function or other things that can develop and require their own distinct antithrombotic management, for example. In young children, however, more severe causes of congenital heart disease tend to more frequently be associated with stroke. And in many cases, those strokes can be early on in life or associated, say, with perioperative complications or other iatrogenic-related causes in, in that way. Again, congenital heart disease can be associated with stroke at, at any point in the life course. But as adult neurologists, most frequently we're seeing very simple lesions like PFO with large shunts, and in children, it tends to be the more complex causes of congenital heart disease.  Dr Berkowitz: Got it. So, let's move on to the blood vessels. Again, in adults, we're usually thinking about atherosclerotic disease, be that of the cervical arteries or of the intracranial arteries. But in your paper, a lot of discussion about the various vasculopathies, arteriopathies that can be cause of stroke in younger adults and in children. Could you talk a little bit more about some of the vasculopathies and vascular conditions that are causes of stroke in the younger population?  Dr Field: Sure. Before I do that, I will say that especially in older younger adults, particularly over the age of thirty-five, and you know, kind of makes me shudder that that's an older younger adult. But, um, in, in any case, certainly conventional vascular risk factors are more common in this population with stroke, especially in those who don't have PFO-associated stroke. Like conventional atherosclerosis, you know, certainly is a cause of stroke in younger adults. But that being said, certainly other vascular causes and vasculopathy in particular is a much more common cause of stroke in younger adults and, and children than it is in older adults. In particular, dissection is an extremely common cause of stroke in younger adults. Generally cervical artery dissection from non-inflammatory vasculopathy, usually on, sometimes on the FMD fibromuscular dysplasia spectrum and, and sometimes, you know, provoked by minor trauma or something post-infectious that may make the vessels a little bit more susceptible. And in younger children, this inflammatory focal cerebral arteriopathy is a distinct cause that is a common cause of stroke in, in young children. There are other causes that can affect the blood vessels, you know, rarer things like vasculitis and vasculopathies that can develop in the context, say, of sickle cell anemia. But in general, as a bucket, vessels are still very important, but the pathology tends to shift.  Dr Berkowitz: Got it. And you, um, alluded to a point that I wanted to ask you about. You mentioned the sort of, there's stroke in the young, and then where do you draw the line at young? Less than sixty, less than thirty-five, and then we've also talked about strokes as young as before the age of birth. Yeah, I'm remembering, is it the Helsinki study, one of the early large series of stroke in younger individuals? I think that, was it eighteen to forty-nine in that or fifty-nine? I don't remember the exact age, but being struck reading that paper as a resident and thinking about the workup for exotic causes we do, right, and when a young patient has a stroke. And correct me if I'm wrong, the most common etiologies of stroke in that series, and I'm curious the other large series yourself have been involved with, have still been vascular risk factors and arrhythmias and things that we, even common, quote unquote, common things in the young, such as dissection or hypercoagulable states. Uh, the things that we sort of tend to think about first are actually less common. But acknowledging that that paper has folks up to the late forties when the vascular risk factors may be, um, unfortunately kicking in earlier, uh, and earlier due to dietary and lifestyle factors. So is that true, or do you have sort of an age cutoff when it's, we say stroke in the young, people sort of think, "Oh, they'd work someone up differently if they're less than sixty, and they have no vascular risk factors or few vascular risk factors." When do we start getting into the kind of younger population where atherosclerosis and cardiac arrhythmias are not number one and two?  Dr Field: I'd say first of all, you and I must have trained around the same time because I was also in my training, really struck by the results of the Helsinki study going, "Wow, I, I really didn't know how much of a role these conventional vascular risk factors still play." And I think we're seeing that information reiterated, unfortunately, like even with higher prevalences and more attributable risk in some of the newer series. There are newer European series looking at stroke in younger adults, and more recently, there's been one that we mentioned in the article from the Florida Stroke Registry. And it's true that generally the burden is in the older younger adults. But what I would say overall in terms of kind of how things guide the workup, you need to look at the patient and consider things. I mean, obviously you don't want to miss things that can be treated differently and identified by tests easily. You know, things like ruling out syphilis or antiphospholipid antibody disease in, in younger patients. You really want to make sure that that's not something that, that you'd miss because, you know, obviously your treatment is going to change. However, certainly we start with the basics for stroke workup in any patient that's coming in. At my center, CT angiography. Some centers it may be MR angiography and echocardiography. We take a careful history. We look at the blood work. We look at the vascular risk factor burden. We find out if there's kind of any worrisome personal history, family history, look at their general health context. I think that really helps to guide how far we go in a particular workup, and it also helps to direct the other investigations and types of follow-up we need to do. For example, if a patient has a fairly suspicious story for dissection, let's say they're getting over a cold, and they went to the gym, and, you know, there was a sudden movement that they did that really produced headache and neck pain, and there's an obvious cervical artery dissection. I'm not going to go too far down testing them for rare infections and doing advanced cardiac imaging unless something shows up on their initial echo, for example. But I will make an effort to do more detailed vascular imaging of the rest of their body, find out careful family history. If there's additional manifestations of a non-inflammatory vasculopathy elsewhere, say consider sending them to medical genetics, or obviously, if this is, you know, a second event, your flags raise even more. So, it really depends on the patient. If I find out that there's, you know, a family history of premature cardiac disease and things like that, you know, obviously we're gonna be keeping a close eye on their cholesterol, making sure that we're not identifying, for example, familial hypercholesterolemia, which is, you know, something that comes up not infrequently where we'll see an LDL in an untreated patient of more than five. I apologize, you're gonna have to do the conversion to American units on that. But there are things we identify and, you know, again, you don't want to fall solely on heuristics and your preconceived notion of, of the patient. You do have to consider the results of the investigations that you do order. But I think you can certainly be mindful in terms of how you direct your workup and in turn, how you direct your follow-up.  Dr Berkowitz: That's great to hear your approach. Yeah, as you said, our approach always begins with the same, coming back to these three categories, right? Doing some type of structural imaging of the heart, rhythm monitoring for the heart, and then vascular imaging of the head and neck. And then I was going to ask you, and you sort of began to answer this question. Yeah. What's next and how far do you go? I think most people think the expanded stroke workup in the young is at a minimum, a TEE if there's been no signal thus far on the original workup. I just mentioned and you spoke about, and then probably hypercoagulable testing and only sending arterial side if there's no shunt and venous and arterial side if there's a shunt. Is that your second pass approach or did I miss anything, or are there other nuances there that are helpful to discuss?  Dr Field: No, I think that's generally in keeping with what I do. I think with TEE being very important. I mean, the first pass are arterial stuff. Really, it's antiphospholipid antibodies and, and making sure there's no cancer. Like you said, only if there's a shunt do I pursue other venous hypercoagulability testing. Again, you [chuckles] kind of reiterate, go through with the history, make sure there's kind of no red flags. And sometimes, obviously, you do your best reasonable job with the first pass workup, and you will find out when someone presents with a second event that it's something very unexpected. Maybe first manifestation, someone with no obvious history and very initially normal-looking imaging, say with, with CATASL or something like Fabry's disease or something where you would consider it if there was kind of a more classical picture. But it wouldn't be something you would do kind of on your first or even second pass workup in the absence of any sort of clinical suspicion, family history, or something along those lines.  Dr Berkowitz: I'm curious just as far as rough percentage. I feel like many of these patients we see it's a patient who's young and who's had a stroke, and the initial first pass has been unremarkable, and we do our TEE, and we do our hypercoagulable workup. Again, antiphospholipid antibodies only if it's-- there's no shunt. And if there's a shunt, adding on some of the venous hypercoagulability protein C, protein S, factor five, Leiden, et cetera. A lot of the times I feel like we don't find anything. What's your sort of general gestalt? Again, as a general neurologist who does a lot of inpatient neurology, I feel like when these cases come up, it's not that common that you say, "Oh, I actually diagnosed protein S deficiency." Or every once in a while, diagnose an antiphospholipid antibody, or you'll find a PFO on TEE. You didn't find on TT. I've maybe found one fibroelastoma in many years. How often do you find something? How often is it just as an adult a cryptogenic stroke in a young adult or child?  Dr Field: So much of what we see is PFO-related, dissection-related, conventional vascular risk factor-related. We do send referrals to medical genetics. Sometimes we'll do testing for rare things like Fabry's or consider other diagnoses. But I mean, those tend to be the exceptions. About one in four to one in five young adults with stroke end up with this cryptogenic label. I like to keep them on my radar for a few reasons. I think, one, it produces tremendous anxiety for them to not have a cause of stroke identified and just to kind of have a generic approach to secondary prevention. So, I think just to kind of keep an eye on them, manage their anxieties each year, make sure there's kind of no updates in, in terms of general secondary preventionAnd sometimes just things dawn on you later or there are new conditions, say things like, you know, DADA2, this, you know, adenosine deaminase deficiency. You know, there are new diagnoses that, that come on the radar. And sometimes treatments change. You know, for example, when I was starting my early career, the evidence hadn't yet been in place for PFO closure, and then all of a sudden, the paradigm completely changed. And you want to make sure that you can get in touch with those patients to reconsider your approach at the time. So I realize that not everybody has the luxury of extended follow-up with their patients, but I think often you can kind of encourage them or their healthcare team or just, you know, patient themselves to keep in touch periodically just to make sure that there haven't been any changes in treatment paradigms or just with your own awareness of particular, you know, diagnoses or, or just kind of readdressing the situation, uh, a year after and seeing if there's anything that may have occurred to you in the interim.  Dr Berkowitz: Perfect. Really illuminating to hear your approach to these challenging cases. And as you said here and then a couple of times, I think, in this interview is in many of these cases it's your first pass, maybe even your second pass, you haven't found anything. And the key is, unfortunately, as distressing as it may be for the patient as well as for us to not have an answer, to just keep following these patients. And sometimes you really can't sort it out until something else happens, either neurologically or systemically, where you say, "Oh, that's what this was." But there would've been no way to know it from the first presentation. So, we've talked a lot about the diagnosis of causes of stroke in younger adults and children. And in the last minute or two here, I just wanted to talk a little bit about treatment. You mentioned early on that you're involved in thrombectomy cases in children. What's the state of evidence or at least state of practice in terms of offering therapies like thrombolysis and thrombectomy in our patient population? I guess it would be under 18, right, who is not studied in the major trials. Do we have evidence and, or in the absence of evidence, what's sort of the, the expert guidance on treating young adults under 18 and children with some of these acute therapies?  Dr Field: So, trying to keep up with the literature on this. You know, certainly the evidence has been more established in a small trial and pediatric registries for use of tPA, tissue plasminogen activator, in children just because, you know, it's been around much longer. In terms of tenecteplase, which I, I really think signifies a, a practice shift in adult stroke because of its, you know, non-inferior efficacy and ease of use and potentially better rates of recanalization over time. In children, to my knowledge, that evidence base is, is limited to case series and anecdotal shifts in availability of drug and, and different practices. So, the evidence base is not particularly strong for tenecteplase in children who are identified within a reasonable amount of time who are still otherwise candidates for thrombolysis, you know, thrombolysis in children. Children who are a little bit older, I think, can't remember the exact age, but generally very young, like neonates, children who are under the age of two, I believe. I would want to double-check that thrombolysis is less commonly used and just because the safety has not really been that well-established. And for thrombectomy, it's now recommended to use thrombectomy in otherwise eligible children in the newest AHA guidelines. It gets a little bit more controversial in very young children. Under the age of six, there's less of an evidence base and, and often it will depend on people's level of comfort in terms of the size of the arteries. It's my understanding that once you get to about age six, the artery diameter is similar to that in fully grown people. But in younger children, I think just because of the catheters, there can be risk of, of injury. So, it's more of a case-by-case conversation with your interventionalist for younger children. And again, the evidence to intervene is not there for very, very young babies, for example.  Dr Berkowitz: That's very helpful to hear the current state of the evidence and the current state of practice, acknowledging, of course, there's not that much evidence, and these are relatively uncommon occurrences, fortunately, for children, but making it challenging for practitioners and practices may, um, vary based on different institutional protocols. So again, today I've been interviewing Dr. Thalia Field about her article on stroke in children and younger adults. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining us today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Moving away from insurance can create fear for dentists who worry patients will leave, the team will resist, or production will suffer. In this episode, Kirk Behrendt brings back Dr. Troy Schmedding, a private practice dentist in Walnut Creek, California, to explain how he transitioned out of insurance participation, rebuilt his practice around quality and communication, and created more control over how he practices. You will learn why team alignment matters, how to communicate insurance changes with patients, and why quality and customer service are essential for an out-of-network model. To learn how one dentist reclaimed control by ditching insurance and prioritizing quality, listen to Episode 1070 of The Best Practices Show!Main Takeaways:Dentists often struggle to leave insurance because of fear and self-limiting beliefs about whether their patients will stay.A practice can become less busy but more productive when it is well-managed and focused on quality care.Going out-of-network requires strong communication with the team and with patients.Patients respond better when the conversation focuses on quality of care rather than complaints about insurance companies.Billing insurance on behalf of patients remains an important customer service step after leaving insurance networks.Patient referrals can become stronger when existing patients value quality, service, and the practice model.A successful out-of-network practice depends on having a team that supports the doctor's vision and communicates well with patients.Snippets:00:00 Introduction to Dr. Troy Schmedding and the topic of moving away from insurance.01:09 Kirk introduces Dr. Schmedding and the Best Practices Show.04:15 Dr. Schmedding explains how insurance reimbursement cuts influenced his decision-making.06:51 Fear and self-limiting beliefs keep dentists from changing their insurance model.10:49 Team alignment is necessary before making major insurance changes.13:54 Referrals shift when patients understand and value the practice model.15:06 Dr. Schmedding shares his perspective on dentists' frustration with Delta Dental.17:54 Kirk and Dr. Schmedding discuss the future of out-of-network private practice.21:28 Dr. Schmedding explains what dentists often misunderstand about his practice model.23:00 Dr. Schmedding discusses his upcoming Smile Source Exchange presentation.24:54 Final thoughts & ClosingGuest Bio/Guest Resources:Dr. Troy Schmedding is a honors graduate of the Arthur A. Dugoni School of Dentistry in San Francisco, California. He maintains a private practice in Walnut Creek, Ca. where he focuses on aesthetic and functional dentistry. An Accredited member of the American Academy of Cosmetic Dentistry, he lectures both nationally and internationally on aesthetics and restorative materials. He has also written and published numerous articles on restorative materials and protocols in numerous dental magazines. Dr Schmedding also serves as a Key Opinion Leader for numerous manufacturers helping develop and bring new products to market.Resources mentioned in this episode:Dr. Troy Schmedding on Instagram: https://www.instagram.com/troyschmeddingdds/Smile Source Exchange: https://smilesource.com/exchangeMore Helpful Links for a Better Practice & a Better Life:The Best Practices Show: https://www.actdental.com/podcast/Best Practices Association: https://www.actdental.com/bpaUpcoming Events & Workshops: https://www.actdental.com/events/Smile Source: https://www.smilesource.com/Subscribe on Apple Podcasts: https://podcasts.apple.comSubscribe on Spotify: https://open.spotify.com

This month we begin a new series on Postural Orthostatic Tachycardia Syndrome (POTS), exploring the diagnosis and management of this increasingly recognized condition in pediatric patients. In this episode, host Paul Wirkus, MD, FAAP and guest Kirti Sivakoti, MD, provide an overview of POTS before discussing current approaches to diagnosis and recent updates in the field. We review the diagnostic criteria, including orthostatic symptoms and the degree of functional impairment, and consider how these factors help guide clinical evaluation and management.The conversation also examines the growing understanding of POTS as a spectrum disorder, with many patients experiencing overlapping symptoms and contributing conditions. Finally, we discuss how to distinguish POTS from vasovagal syncope and review current thinking on the underlying causes and pathophysiology of POTS. This episode provides pediatricians with a practical framework for recognizing and evaluating children and adolescents with orthostatic intolerance.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Your Daughter Shouldn't Be Starting Her Period at Nine Something is happening to our girls. And the medical establishment's answer is to move the goalposts — lower the age, redefine normal, and call it a day. Dr. Terri isn't buying it. In this episode, she sits down with Dr. Tara Scott, board-certified OB/GYN, integrative medicine physician, and nationally recognized women's hormone expert, to go deep on one of the most urgent and overlooked conversations in women's health: why young girls are entering puberty earlier than ever before, what's driving it, and what parents can actually do about it. This isn't just about food or beauty products, though those matter. It starts in the womb. Researchers have found over 300 different chemicals in the umbilical cords of newborns — phthalates, parabens, forever chemicals, pesticide residues — all of them endocrine disruptors that mimic estrogen and tell the body to activate early. Both Dr. Terri and Dr. Scott watched this play out with their own daughters. Dr. Terri's first daughter, born before her integrative medicine shift, started her period at ten. Dr. Scott switched her twins to organic milk at age four after reading the research on hormones in conventional dairy and her younger daughter started her period at almost fourteen. The data isn't abstract. It lived in their own homes. And it's pointing somewhere every parent needs to understand. If you have daughters, granddaughters, or a young woman in your life this episode is for you. What you'll discover: Why the American Academy of Pediatrics is considering moving the definition of normal puberty younger and why Dr. Scott says that's exactly the wrong response [07:29] How endocrine-disrupting chemicals enter the body before birth and compound every year of a child's life [01:33] The milk experiment: what happened when Dr. Scott bought organic milk for her daughters and conventional for her husband and son [09:24] Why melatonin is a selective estrogen receptor modulator and what screen time at night is doing to hormone development [13:04] The Hormone Zoomer: what it tests for, what Dr. Scott found when she ran it on herself, and why even people who've already cleaned up their lifestyle may be surprised [42:32] What a real endocrine detox looks like, sweating, water quality, sleep, cruciferous vegetables, and why sulforaphane is the one thing Dr. Scott would recommend across the board [47:41] Dr. Scott's message to every woman in her 20s and 30s: no woman is too young to get her hormones checked [50:19] How to have the generational conversation with mothers and grandmothers who grew up in a completely different era of food and medicine [03:47] The goalpost didn't move. Something changed. And we can fix it. The Dr. Terri Show is presented by EVEXIAS Health Solutions.Learn more and find a provider near you at evexias.com Connect with Dr. Terri:

Host Dr. Joel Berg speaks with Dr. Chelsea Fosse, Vice President of the AAPD Research & Policy Center (RPC) on the current hot topics in public health and how the RPC is working to make an impact. Dr. Fosse delves into the impacts of federal updates on pediatric dentistry and the organizations advocating for the health of children. She shares a timeline for the anticipated impacts of H.R. 1 to families and how AAPD members and other healthcare professionals can turn to the RPC for support with state-specific questions relating to Medicaid or other legislation. Guest Bio: Chelsea Fosse, DMD, MPH is the Vice President, Research & Policy Center at the American Academy of Pediatric Dentistry (AAPD). She is boarded in dental public health. Before shifting her career to work in oral health policy research, she worked as a general dentist treating adults with disabilities.   At AAPD, Chelsea leads a team focused on Medicaid policy and program administration, evidence-based dental care, access to high quality and safe dental care, the pediatric dental workforce, and other contemporary issues in oral health, public health, and health policy. She was previously at the American Dental Association (ADA) Health Policy Institute (HPI) where she led policy analysis for issues related to Medicaid and studied the oral health workforce and the industry's response to the COVID-19 pandemic. Before dental school, she worked in the Division of Children with Special Needs at the American Academy of Pediatrics. She currently serves as President of the Board of Directors at Well Child Center, a community-based organization offering WIC, dental, and other social and health services in Elgin, IL.   Chelsea received her bachelor's from The University of Texas in 2009, DMD from Rutgers in 2017, and MPH from Columbia University in 2019. She completed a general practice residency at Helen Hayes Hospital in 2018 and a dental public health residency at Jacobi Medical Center in 2020.  See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Larry Kramer has been President and Vice Chancellor of the London School of Economics and Political Science 1 April 2024.He served as President of the William and Flora Hewlett Foundation from 2012 to 2024. Under his leadership, the foundation significantly adapted its strategies to meet changing circumstances and seize new opportunities, including new efforts to respond to pressing and timely challenges related to democracy, economics, climate change, and racial justice.Larry spent most of his career in the academy, most recently as the 15th Dean of Stanford Law School, a position he assumed in 2004. During his tenure, he spearheaded significant educational reforms. He pioneered a new model of multidisciplinary legal studies, while growing the clinical education program, incorporating a public service ethos, and enlarging the physical campus.Previously, Larry researched and taught at the University of Chicago, the University of Michigan, and New York University, where he served as Associate Dean for Research and Academics and Russell D. Niles Professor of Law. He clerked for U.S. Court of Appeals Judge Henry J. Friendly of the Second Circuit and U.S. Supreme Court Justice William J. Brennan Jr., following his education. Larry holds an A.B. in Psychology and Religious Studies from Brown University and a J.D. from the University of Chicago Law School.Larry's teaching and scholarly interests include American legal history, constitutional law, federalism, separation of powers, the federal courts, conflict of laws, and civil procedure. He is the author of numerous articles and books, including The People Themselves: Popular Constitutionalism and Judicial Review.Larry is a fellow of the American Academy of Arts and Sciences and a member of the American Philosophical Society. He serves as board chair of iCivics and has been a director on the boards of numerous nonprofit organizations, including the Silicon Valley Community Foundation, the ClimateWorks Foundation, the Independent Sector, and Equal Justice Works. Hosted on Acast. See acast.com/privacy for more information.

In this powerful episode of I Am Refocused Radio, host Shemaiah Reed sits down with Joy Kong, MD, a UCLA-trained, triple board-certified physician recognized for her work in regenerative medicine, stem cell science, and anti-aging innovation. Dr. Kong is also the founder of Chara Health and the American Academy of Integrative Cell Therapy, where her work focuses on education, cellular health, longevity, and ethical approaches to regenerative medicine.This conversation explores the future of healing through regenerative medicine, including stem cell therapy, cellular repair, longevity science, anti-aging, brain health, recovery, inflammation, and how new medical approaches are changing the way people think about wellness from the inside out.Dr. Kong brings a thoughtful and compassionate perspective to a field that is growing quickly, helping listeners better understand what regenerative medicine is, why it matters, and how science, education, and ethics must work together as health innovation moves forward.Whether you are curious about anti-aging, interested in the future of medicine, or looking for a deeper understanding of how the body can support healing and renewal, this episode offers insight, clarity, and inspiration.This interview is for educational and informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional regarding your personal health decisions.Connect with Joy Kong, MD:https://joykongmd.com/Watch more interviews:YouTube.com/@RefocusedNetworkVisit I Am Refocused Radio:https://www.iamrefocusedradio.com/Become a supporter of this podcast: https://www.spreaker.com/podcast/i-am-refocused-radio--2671113/support.Subscribe now at YouTube.com/@RefocusedNetworkThank you for your time. 

In this episode of Hunger for Wholeness, Ilia Delio continues her conversation with Robert Geraci on the ethical future of technology, the possibility of a global mind, and the stories we need to tell if civilization is to flourish. Together, they ask how AI might help us build shared spaces of learning, dialogue, and human connection rather than deepen division, surveillance, and algorithmic isolation.Ilia imagines noospheric classrooms and a global heart, where technology becomes a medium for shared values across cultures, religions, and planetary communities. Geraci reflects on the need for humility, public goods, meaningful work, and stories that draw us toward a better future rather than trap us in conflict, wealth, and power.Later in the episode, Geraci discusses his book Future-Proofing Humanity, exploring existential risk, technological culture, the Epic of Gilgamesh, and the importance of civilization as an unfinished project. Rather than fearing technology itself, Ilia and Robert invite us to ask what kind of humanity our technologies are calling us to become.ABOUT ROBERT GERACIRobert M Geraci is the Knight Distinguished Chair for the Study of Religion & Culture at Knox College. His research explores religion, science and technology in the contemporary world. He is the author of Apocalyptic AI: Visions of Heaven in Robotics, Artificial Intelligence, and Virtual Reality (Oxford 2010), Virtually Sacred: Myths and Meaning in World of Warcraft and Second Life (Oxford 2014), Temples of Modernity: Nationalism, Hinduism, and Transhumanism in South Indian Science (Lexington 2018), Futures of Artificial Intelligence: Perspectives from India and the U.S. (Oxford 2022), and Futureproofing Humanity: Existential Risk and the Technomyths of Human Engineering, Artificial Intelligence, and Our Future among the Stars (self 2026). He has been a visiting researcher at Carnegie Mellon University's Robotics Institute, the Indian Institute of Science and the National Institute for Advanced Studies in Bangalore, India. His research has been supported by the US National Science Foundation, the Republic of Korea National Research Foundation, the American Academy of Religion and two Fulbright-Nehru research awards. He enjoys kayaking, hiking, videogames, and Dungeons & Dragons but doesn't really have time for any of it. Join us for the Center's 10th Anniversary Conference, November 9–11 in Villanova, Pennsylvania, with a virtual option available. In a time of deep political, social, ecological, and spiritual division, this gathering explores how love can become a compass for transformation. Learn more and register at christogenesis.org/conference. We are currently in the midst of our summer fundraiser, From Fear to Hope: Change and the Perpetual Growth of Life. As the Center marks its tenth anniversary, your support sustains our conferences, webinars, publications, and emerging global learning platform. Please consider making a generous contribution at christogenesis.org/donate.Support the showA huge thank you to all of you who subscribe and support our show! Support for A Hunger for Wholeness comes from the Fetzer Institute. Fetzer supports a movement of organizations who are applying spiritual solutions to society's toughest problems. Get involved at fetzer.org.Visit the Center for Christogenesis' website at christogenesis.org/podcast to browse all Hunger for Wholeness episodes and read more from Ilia Delio.  Follow us on Facebook and Instagram for episode releases and other updates.

In this episode of The Skin Real, Dr. Mary Alice Mina sits down with fellow board-certified dermatologist Dr. Amaris Geisler, a specialist in vulvar dermatoses based in Atlanta, to break the silence around a body part most women can't even name correctly — the vulva. They cover what the vulva actually is (versus the vagina), the most common conditions dermatologists see there (lichen sclerosis, eczema, psoriasis, and even skin cancer), and why so many women get dismissed with a yeast infection diagnosis instead of a real workup. Dr. Geisler explains the lifelong treatment path for lichen sclerosis, the risks of leaving it untreated (scarring and squamous cell carcinoma), how symptoms and pigmentary changes can present differently in skin of color, and why products like Vagisil and fragranced washes often cause more harm than good. The conversation also tackles the psychological and relational toll of vulvar skin disease, and closes with practical advice on red flags, finding a specialist, and what a proper workup with a dermatologist and gynecologist looks like. The throughline: your vulva is skin, it deserves the same care and attention as anywhere else on your body, and there is nothing shameful about asking for help. In this episode:  00:00 — The Symptom No One Talks About 00:40 — Show Intro & Medical Disclaimer 01:35 — Meet Dr. Amaris Geisler & Why This Conversation Matters 03:15 — How She Fell Into Vulvar Dermatology 05:55 — What Is the Vulva, Really? (Anatomy 101) 07:55 — The Most Common Vulvar Skin Conditions 10:10 — Yes, Skin Cancer Can Happen Here Too 13:25 — Why Self-Checks and Full-Body Exams Matter 15:25 — Lichen Sclerosis Symptoms: Itching, Pain & Fissures 16:55 — Treatment: Steroids and the Lifelong Maintenance Plan 19:25 — The Real Risks of Skipping Treatment (Scarring & Cancer) 21:25 — Menopause, Hormones & the Lichen Sclerosis Connection 24:25 — When (and How) Biopsies Are Actually Done 26:55 — Cysts, Fear, and the "Is This an STD" Question 28:25 — The Truth About Hygiene (Stop Douching) 30:25 — Allergic Reactions: Vagisil, Fragrance & What's Actually Safe 32:55 — Vulvar Conditions in Skin of Color 34:55 — The Mental Health Toll of Vulvar Skin Disease 36:10 — Sex, Intimacy & Reassurance for Partners 36:55 — Red Flags: When to See a Doctor Immediately 37:40 — How to Find a Vulvar Specialist 38:15 — What a Proper Workup Looks Like 38:45 — Final Advice: Treat Your Vulva With Kindness 39:15 — Outro: Subscribe & More Resources at theskinreal.com Want a deeper look? Watch the full episode on YouTube for a more visual experience of today's discussion. This episode is best enjoyed on video—don't miss out!

Jon is the co-founder of Pickle, as well as a Physical Therapist. He's been featured by organizations such as NYU, the University of Oxford,  WebPT,  and the United Nations, working with healthcare executives around the globe on workforce strategy and big data analytics.   Jonathon holds an MBA from the University of Oxford (UK) and a DPT from Virginia Commonwealth University. He is also a board-certified orthopedic clinical specialist, and fellow of the American Academy of Orthopedic Manual Physical Therapists.  

One of the promises of artificial intelligence is that it will mimic, and perhaps even improve, on human thinking. One of those hoped-for improvements was that AI would not exhibit human biases. Turns out that in one area, AI can indeed mimic human thinking, and it's in that field of bias. As Harvard psychologist Mahzarin Banaji -- one of the creators of the widely used implicit bias test -- explains in this Social Science Bites podcast, AI platforms both mimic human bias and even amplify it. In her second appearance on the podcast series, Banaji tells interviewer David Edmonds that even she was surprised how overtly bias shows up in AI results. She recalls her jaw dropping after she queried a large language model about what biases it might have, and it replied "I am a white male," and then how, a month later when queried the same thing it came back with a lengthy 'correct' answer about how it could be biased. "[W]hat stunned me, and why I began to work on these LLMs, is because it became clear that the creators of these models were actually doing us a massive disservice by creating in these machines two kinds of thought: what the machine knows that it's learned, and now what the machine is going to say, which I'll just call LLM hypocrisy."  Banaji is the Richard Clarke Cabot Professor of Social Ethics in the Department of Psychology at Harvard, a position she has held since 2002. She is also the first Carol K. Pforzheimer Professor at the Radcliffe Institute for Advanced Study, and the George A. and Helen Dunham Cowan Chair in Human Dynamics at the Santa Fe Institute. A former president of the Association of Psychology Science (2010-11), she was named William James Fellow by the APS and is also a fellow of the American Academy of Political and Social Science, the Society for Experimental Psychologists, Society for Experimental Social Psychology, and the American Academy of Arts and Sciences.